Embodiments disclosed herein relate to methods and systems for performing an automated assay, and particularly to performing a plurality of assays on a plurality of samples on an automated instrument.
The medical diagnostics industry is a critical element of today's healthcare infrastructure. In the last decade, the use of nucleic acid based assays for diagnostic testing has become increasingly more common. The automation of processing and testing samples in diagnostic testing is appealing, as it minimizes experimental variability and reduces the need for highly trained technicians. In addition to benefits in the field of diagnostics, automation of processing and testing samples has facilitated high throughput testing.
Understanding that processing samples for purposes such as diagnostic testing or high throughput testing may break down into several key steps, it is often desirable to automate one or more steps. For example, in the context of diagnostics, a biological sample, such as those obtained from a patient, can be used in nucleic acid amplification assays in order to amplify a target nucleic acid (e.g., DNA, RNA, or the like) of interest. Once amplified, the presence of a target nucleic acid, or amplification product of a target nucleic acid (e.g., a target amplicon) can be detected, wherein the presence of a target nucleic acid and/or target amplicon is used to identify and/or quantify the presence of a target (e.g., a target microorganism or the like). Often, nucleic acid amplification assays involve multiple steps, which can include nucleic acid extraction, nucleic acid amplification, and detection. It is desirable to automate certain steps of these processes.
There is a need for improved methods and devices for carrying out assays on multiple samples in parallel. The embodiments described herein address this need and can advantageously be used in clinical and research settings.
The present technology relates to methods and systems for performing an automated assay, and particularly to performing a plurality of assays on a plurality of samples on an automated instrument. In some embodiments of the present technology, such methods and systems can permit the concurrent performance of discrete assay workflows on an instrument when the assay workflows are compatible, and can prevent the concurrent performance of incompatible assays within the same workstation. Some embodiments relate to performing a plurality of user-defined protocols (UDP) on an automated instrument. Some embodiments relate to performing a plurality of assay definition files (ADF) developed by an assay manufacturer. Some embodiments relate to performing one or more UDPs, optionally in combination with one or more ADFs, concurrently on the same automated instrument.
In some embodiments of the technology presented herein, methods of performing an automated assay on a plurality of samples are provided that allow for improved reliability and ease of use when performing an assay on an automated instrument. The methods can include providing an automated instrument comprising a first workstation and a second workstation, each of the first and second workstations configured to receive and processes a plurality of samples according to a plurality of different automated assay workflows, wherein each different automated assay workflow has an associated unique assay definition or user-defined protocol file; determining whether two discrete assay workflows are compatible or incompatible with each other for concurrent processing on the automated instrument; and performing the discrete assay workflows concurrently on the instrument when the assays are compatible.
In some embodiments, the assay definition or user defined protocol file can comprise a first level compatibility index value, and wherein the determining step can comprise: (a) selecting a first assay from among a first list of available assays; and (b) evaluating which of a plurality of other available assays have an assay definition file comprising the same first level compatibility index value as the first assay, wherein the same first level compatibility index value is indicative of first-level compatibility.
In some embodiments, the evaluating step can comprise (b1) identifying any assays which have first level compatibility index values different from the first compatibility index value of the first assay; and (b2) providing a second list of second assays, wherein the second list excludes any assay having a first level compatibility index value different from the first compatibility index value of the first assay.
In some embodiments, each assay definition file can comprise a second level compatibility index value, and wherein the determining step further can comprise (c) evaluating which of a plurality of other available assays have an assay definition file comprising the same second level compatibility index value as the first assay, wherein the same second level compatibility index value is indicative of second-level compatibility.
In some embodiments, the evaluating step can comprise (c1) identifying any assays which have second level compatibility index values different from the second compatibility index value of the first assay; and (c2) providing a second list of second assays, wherein the second list excludes any assay having a second level compatibility index value different from the second compatibility index value of the first assay.
In some embodiments, the first level compatibility can comprise compatibility of performing two assays concurrently at a single workstation, the parameters selected from the group consisting of: incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature, workstation time demands, regulatory classification, business considerations, and a combination thereof.
In some embodiments, the second level compatibility can comprise compatibility of performing two assays concurrently on the automated instrument, the parameters selected from the group consisting of: regulatory classification, workflow incompatibility, business considerations, and a combination thereof.
In some embodiments, the instrument prevents the concurrent performance of incompatible assays within the same workstation when the first compatibility indexes are different. In some embodiments, the two discrete assay workflows are performed in the same workstation. In some embodiments, the instrument is prevented from concurrently performing assays with different second compatibility index values. In some embodiments, two assays have the same first level compatibility index value and have different second level compatibility index values. In some embodiments, the difference in the second level compatibility index values can comprise a business reason. In some embodiments, the difference in the second level compatibility index values can comprise a regulatory classification.
In some embodiments, if the assays are compatible, the method can further comprise one or more of the following (d) initiating an assay-specific sample preparation script on the instrument; (e) comparing identifying indicia on a consumable package to a set of assay-specific identifying data stored on the instrument; (f) initiating an assay-specific load cartridge script on the instrument; (g) comparing levels of detectable signals fluorescence ratios in a loaded cartridge to a set of assay-specific detectable signal data stored on the instrument to determine whether the cartridge was successfully loaded; (h) initiating an assay-specific reaction script on the instrument; (i) initiating an assay-specific data analysis algorithm on the instrument; or (j) deriving a final call for the assay, based on one or more assay-specific result algorithms or scripts.
In some embodiments, the assay protocol can comprise a reaction selected from the group selected from: Polymerase Chain Reaction (PCR), Transcription Mediated Amplification (TMA), Oligonucleotide Ligation Assay (OLA), Ligase Chain Reaction (LCR), Rolling Circle Amplification (RCA), Strand Displacement Amplification (SDA), and a hybridization reaction.
Also presented herein is a system for performing an automated assay, the system comprising an automated instrument comprising a first workstation and a second workstation, each of the first and second workstations configured to receive and processes a plurality of samples according to a plurality of different automated assay workflows, wherein each different automated assay workflow has an associated unique assay definition file or user-defined protocol file; a processor; a storage capacity; and a program for performing an automated assay, the program comprising instructions for determining whether two discrete assay workflows are compatible or incompatible with each other for concurrent processing on the automated instrument; and performing the discrete assay workflows concurrently on the instrument when the assays are compatible.
In some embodiments of the above system, the assay definition file or user defined protocol file can comprise a first level compatibility index value, and wherein the determining step can comprise: (a) selecting a first assay from among a first list of available assays; and (b) evaluating which of a plurality of other available assays have an assay definition file comprising the same first level compatibility index value as the first assay, wherein the same first level compatibility index value is indicative of first-level compatibility.
In some embodiments of the above system, the evaluating step can comprise (b1) identifying any assays which have first level compatibility index values different from the first compatibility index value of the first assay; and (b2) providing a second list of second assays, wherein the second list excludes any assay having a first level compatibility index value different from the first compatibility index value of the first assay.
In some embodiments of the above system, each assay definition file can comprise a second level compatibility index value, and wherein the determining step further can comprise (c) evaluating which of a plurality of other available assays have an assay definition file comprising the same second level compatibility index value as the first assay, wherein the same second level compatibility index value is indicative of second-level compatibility.
In some embodiments of the above system, the evaluating step can comprise (c1) identifying any assays which have second level compatibility index values different from the second compatibility index value of the first assay; and (c2) providing a second list of second assays, wherein the second list excludes any assay having a second level compatibility index value different from the second compatibility index value of the first assay.
In some embodiments of the above system, the first level compatibility can comprise compatibility of performing two assays concurrently at a single workstation, the parameters selected from the group consisting of: incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature, workstation time demands, regulatory classification, business considerations, and a combination thereof.
In some embodiments of the above system, the second level compatibility can comprise compatibility of performing two assays concurrently on the automated instrument, the parameters selected from the group consisting of: regulatory classification, workflow incompatibility, business considerations, and a combination thereof.
In some embodiments of the above system, the instrument prevents the concurrent performance of incompatible assays within the same workstation when the first compatibility indexes are different. In some embodiments, the two discrete assay workflows are performed in the same workstation. In some embodiments, the instrument is prevented from concurrently performing assays with different second compatibility index values. In some embodiments, two assays have the same first level compatibility index value and have different second level compatibility index values. In some embodiments, the difference in the second level compatibility index values can comprise a business reason. In some embodiments, the difference in the second level compatibility index values can comprise a regulatory classification.
In some embodiments of the above system, if the assays are compatible, the system can further comprise instructions for one or more of the following (d) initiating an assay-specific sample preparation script on the instrument; (e) comparing identifying indicia on a consumable package to a set of assay-specific identifying data stored on the instrument; (f) initiating an assay-specific load cartridge script on the instrument; (g) comparing levels of detectable signals in a loaded cartridge to a set of assay-specific detectable signal data stored on the instrument to determine whether the cartridge was successfully loaded; (h) initiating an assay-specific reaction script on the instrument; (i) initiating an assay-specific data analysis algorithm on the instrument; or (j) deriving a final call for the assay, based on one or more assay-specific result algorithms or scripts.
In some embodiments of the above system, the assay protocol can comprise a reaction selected from the group selected from: Polymerase Chain Reaction (PCR), Transcription Mediated Amplification (TMA), Oligonucleotide Ligation Assay (OLA), Ligase Chain Reaction (LCR), Rolling Circle Amplification (RCA), Strand Displacement Amplification (SDA), and a hybridization reaction.
In some embodiments of the above system, the system further can comprise a bar code reader. In some embodiments of the above system, the identifying indicia can comprise a bar code.
Also presented herein is a method of performing a plurality of compatible discrete assays concurrently on a single automated instrument, the method comprising, for each discrete assay: providing an automated instrument comprising a first workstation and a second workstation, each of the first and second workstations configured to receive and processes a plurality of samples according to a plurality of different automated assay workflows, wherein each different automated assay workflow has an associated unique assay definition file or user-defined protocol file comprising a first level compatibility index value and a second level compatibility index value; selecting a first assay from among a first list of available assays; evaluating which of a plurality of other available assays have an assay definition file or user-defined protocol file comprising the same first level compatibility index value as the first assay, wherein the same first level compatibility index value is indicative of compatibility for concurrent processing on the same workstation of the automated instrument; evaluating which of a plurality of other available assays have an assay definition file or user-defined protocol file comprising the same second level compatibility index value as the first assay, wherein the same second level compatibility index value is indicative of compatibility for concurrent processing on the automated instrument; and performing the discrete assay workflows concurrently on the instrument when the assays are compatible.
Automated diagnostic instruments are now able to carry out processing and testing of multiple samples in parallel. These devices can advantageously be used in high throughput to facilitate the sample preparation and testing. By way of example, automated diagnostic instruments can prepare samples for nucleic acid amplification assays, and perform the amplification and detection. Depending on the type of samples and the type of assay, however, many times, assay protocols are not compatible with each other on the same instrument, either because of physical constraints on the instrument, or for business reasons. For example, any two assay protocols may have different incubation times, lysis times, reagent volumes, reagent types, incubation temperatures, lysis temperatures, workstation time demands, or other parameters that render it impossible for the instrument to perform different assays in samples in a single workstation, or even on the same instrument. In addition to physical constraints, regulatory classifications and business considerations are each factors which may prevent the instrument from processing samples concurrently. In order to address this issue, users had to manually compare assay protocols on a chart or table to determine whether they can be performed concurrently on the same rack, or even on different racks of the same instrument. Such manual approaches can be error prone, as well as inefficient and labor intensive. Thus, there exists a great need for improved methods to identify compatible assay protocols and prevent incompatible assay protocols from being performed concurrently.
In accordance with the above, provided herein are methods and systems for performing an assay protocol on an automated instrument. In some embodiments of the present technology, such methods and systems can permit the concurrent performance of discrete assay workflows on an instrument when the assay workflows are compatible, and can prevent the concurrent performance of incompatible assay protocols within the same instrument. The methods provided herein allow for improved reliability and ease of use when performing an assay on an automated instrument.
Accordingly, provided herein is a method of providing an automated instrument comprising a first workstation and a second workstation and a common service that is shared by both workstations, each of the first and second workstations configured to receive and processes a plurality of samples according to a plurality of different automated assay workflows, wherein each different automated assay workflow has an associated unique assay definition or user-defined protocol file; determining whether two discrete assay workflows are compatible or incompatible with each other for concurrent processing on the automated instrument; and performing the discrete assay workflows concurrently on the instrument when the assay protocols are compatible.
As used herein, the terms “workstation,” “rack” and like terms refer to an assembly that can hold a plurality of samples within an instrument designed to process those samples together. Thus, two workflows which can be performed concurrently on the same rack are designated herein as “rack-compatible.”
Two workflows which can be performed concurrently on the same instrument are designated herein as “run-compatible.” In certain embodiments, two run-compatible workflows are not compatible on the same rack, but can be performed on separate racks in the instrument. In certain embodiments, two run-compatible workflows are compatible on the same rack. In certain other embodiments, two run-incompatible workflows are compatible on the same rack, but cannot, for any one of a variety of reasons, be performed concurrently on the same instrument.
As used herein, the terms “workflow,” “assay workflow,” “assay,” “assay protocol,” “test,” and like terms refer to a procedure for processing a sample. In typical embodiments, a workflow can include sample preparation steps, such as cell lysis, nucleic acid extraction, nucleic acid purification, nucleic acid digestion, nucleic acid modification, protein extraction, protein purification, and the like. Several methods of nucleic acid extraction useful in the embodiments disclosed herein are known in the art. Exemplary discussions of nucleic acid extraction can be found, for example, in U.S. patent application Ser. No. 12/172,214, filed Jul. 11, 2008, U.S. patent application Ser. No. 12/172,208, filed Jul. 11, 2008, and U.S. patent application Ser. No. 11/281,247, filed Nov. 16, 2005, all of which are incorporated herein by reference in their entirety. Likewise, exemplary discussions of protein extraction can be found, for example, in U.S. Pat. Nos. 8,053,239 and 6,864,100, both of which are incorporated herein by reference in their entirety.
In some typical embodiments, a workflow can also include nucleic acid amplification reactions. In some typical embodiments, a workflow can further include data analysis procedures.
Accordingly, in certain embodiments, workflows are not directly compatible with each other due to physical differences, such as incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature, workstation time demands, and the like. Each of these parameters place unique physical restraints on the motion and capacity of either the workstation itself or on a shared service resource within an automated instrument. For example, an RNA extraction protocol, a DNA extraction protocol, and a protein extraction protocol may each require different motions for a pipetting head on an instrument, and therefore cannot be processed at the same time on the same workstation. By way of another example, a PCR assay and an assay based solely upon hybridization of detectable probes to a target may require different temperature cycling and timing requirements, and therefore cannot be processed at the same time. It will be appreciated that any physical, temporal or other limitation can present a reason for which two workflows are not directly compatible with each other.
In certain embodiments, incompatibility is driven by physical restraints on motion and capacity of a shared service resource within an automated instrument that is shared by two or more workstations. As illustrated in
The physical, temporal or other parameters need not be identical between assays in order to indicate compatibility. Rather, parameters can fall within a range which confers compatibility of, for example, a shared resource. Table 2 in Example 1 below provides an example for assays with parameters that vary within a range, yet still maintain compatibility, whereas assays with parameters outside any one range are no longer compatible.
In addition, workflows that are otherwise physically compatible on an instrument can nonetheless be incompatible for other reasons. In certain embodiments, two workflows cannot be performed concurrently in order to comply with regulatory restraints. For example, if one assay protocol has been approved by a regulatory agency such as the United Stated Food and Drug Administration (FDA), that agency may stipulate that the assay protocol cannot be performed concurrently with an unapproved assay protocol. Likewise, in certain embodiments, a manufacturer or user of instruments, consumable materials, or reagents may be under contractual restrictions or other business limitations, under which two workflows cannot be performed concurrently on the same instrument. It will be appreciated that incompatibility can be determined for any reason for which a manufacturer or user determines that two workflows should be incompatible. The methods and systems provided herein make it possible to identify compatible workflows and perform a plurality of compatible workflows on the same instrument at the same time.
As illustrated in
Assay Definition Files
In embodiments of the methods and systems provided herein, each different automated assay workflow has an associated unique assay definition or user-defined protocol file. As used herein, the term assay definition file (ADF) refers to a file that provides at least some, and typically all of the assay specific parameters for that workflow. In addition, an ADF can provide compatibility index values for a particular workflow. In typical embodiments, the ADF can contain all of the information needed to run the assay on an automated instrument. One function of the ADF is to provide a layer of independence between the instrument and the assay. This independence provides the mechanism by which an instrument manufacturer or assay reagent manufacturer can release new assay protocols for an instrument without producing major revisions to the instrument software.
An ADF can comprise one or more of the components set forth in Table 1 below. In particular, the ADF can include the two-level index values for rack and run compatibility.
Thus, in some embodiments of the methods and systems provided herein, if the assay protocols are compatible, the ADF can include instructions for performing one or more of the following: initiating an assay-specific sample preparation script on the instrument; comparing identifying indicia on a consumable package to a set of assay-specific identifying data stored on the instrument; initiating an assay-specific load cartridge script on the instrument; comparing levels of detectable signals in a loaded cartridge to a set of assay-specific detectable signal data stored on the instrument to determine whether the cartridge was successfully loaded; initiating an assay-specific reaction script on the instrument; initiating an assay-specific data analysis algorithm on the instrument; or deriving a final call for the assay, based on one or more assay-specific result algorithms or scripts. The detectable signals that are compared during a load cartridge script can be any suitable detectable signal that indicates proper loading. In typical embodiments, the detectable signal is fluorescence, and the ratio of fluorescence at various wavelengths in a sample or reagent can be compared to set of pre-determined fluorescence data in order to determine whether the cartridge was properly loaded.
In some embodiments, the ADF can also comprise a reaction including, but not limited to: Polymerase Chain Reaction (PCR), Transcription Mediated Amplification (TMA), Oligonucleotide Ligation Assay (OLA), Ligase Chain Reaction (LCR), Rolling Circle Amplification (RCA), Strand Displacement Amplification (SDA), and a hybridization reaction.
Example 5 below describes an exemplary use of an ADF file to run assay protocols on an instrument.
Typically, when a new assay is made available to a customer, the corresponding ADF is installed on the instrument. Once an ADF is installed on the instrument, that assay is then available for execution on the instrument. The instrument software can then use the index values to control addition of tests to a run worklist. If assay protocols share the same rack index value, then they are allowed to be in the worklist in contiguous positions in a single rack. If two assay protocols have a different run index, then they can not be in the same run worklist. When a user selects the first assay to be included in a run, the software checks the compatibility index values of all other assay protocols available on the instrument and modifies the list of assay protocols that the user can select according to the rules listed above, thereby ensuring that the customer does not choose incompatible assay protocols.
An ADF may be provided in any suitable format. For example, the ADF could be provided by a manufacturer on a storage medium such as CD-ROM or USB key, or downloaded from the manufacturer and then transferred to the terminal that controls the instrument. Multiple ADFs, each defining a distinct assay protocol, can thus be installed on the same instrument. Advantageously, the methods and systems provided herein make it possible for the system to identify assay protocols with the same compatibility index values, rather than force a user to consult a chart or table.
User Defined Protocols
In certain embodiments, assay parameters are determined by the user, rather than the manufacturer. These user defined protocols (UDP) can also be assigned first-level and second-level compatibility index values to ensure compatibility with other commercially-developed assay protocols. One of the benefits of the indexes and assay definition files is that it provides a firewall between user defined assay protocols and commercially-developed assay protocols that also covers compatibility. The index values can be used to set up unique controls for user defined protocols which are different from the index values for commercially-developed assay protocols. In the embodiment illustrated in
Thus, as illustrated in
It will be appreciated that new extraction kits, PCR assay types, and other reagents can be provided by a manufacturer with a file similar to an ADF. Thus, when such files are installed on an instrument, and a new UDP is created, the index values for one or more UDPs may be updated accordingly.
First Level Compatibility Index Value
In some embodiments, the assay definition or user defined protocol file can comprise a first level compatibility index value. Typically, the first level compatibility index value refers to rack compatibility. However, in certain other embodiments, the first level compatibility index value refers to run compatibility and the second level index value refers to rack compatibility. Thus, the method can comprise (a) selecting a first assay protocol from among a first list of available assay protocols; and (b) evaluating which of a plurality of other available assay protocols have an assay definition file comprising the same first level compatibility index value as the first assay. In typical embodiments, two assay protocols having the same first level compatibility index value is indicative of first-level compatibility. It will be appreciated, however, that any suitable mechanism that can assign and identify compatibility values to individual assays can serve in the methods and systems provided herein. Thus, in some embodiments, two assay protocols that are rack compatible may have different first level index values. However, for convenience in this disclosure, two assay protocols with first level compatibility are considered as having the same first level compatibility index value.
The list of available assay protocols can change as the user selects one or more assay protocols to perform, and first level compatibility is evaluated. As such, the evaluating step (b) can comprise the steps of (b1) identifying any assay protocols which have first level compatibility index values different from the first compatibility index value of the first assay; and (b2) providing a second list of second assay protocols, wherein the second list excludes any assay having a first level compatibility index value different from the first compatibility index value of the first assay.
In some embodiments, the first level compatibility can take into consideration any parameter that could prevent performance of two assay protocols concurrently at a single workstation. Such parameters are known to those of skill in the art, and can include, for example, physical parameters such as incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature, workstation time demands, and the like. Further, other parameters can include considerations such as regulatory classification, business considerations, and the like.
Second Level Compatibility Index Value
In some embodiments, the assay definition or user defined protocol file can comprise a second level compatibility index value. Typically, the second level compatibility index value refers to run compatibility. However, in certain other embodiments, the second level compatibility index value refers to rack compatibility and the second level index value refers to run compatibility. Thus, the method can comprise (c) evaluating which of a plurality of other available assay protocols have an assay definition file comprising the same second level compatibility index value as the first assay, wherein the same second level compatibility index value is indicative of second-level compatibility. In typical embodiments, two assay protocols having the same second level compatibility index value is indicative of second level compatibility. It will be appreciated, however, that any suitable mechanism that can assign and identify compatibility values to individual assays can serve in the methods and systems provided herein. Thus, in some embodiments, two assay protocols that are run compatible may have different second level index values. However, for convenience in this disclosure, two assay protocols with second level compatibility are considered as having the same second level compatibility index value.
The list of available assay protocols can change as the user selects one or more assay protocols to perform, and second level compatibility is evaluated. As such, the evaluating step (c) can comprise the steps of (c1) identifying any assay protocols which have second level compatibility index values different from the second compatibility index value of the first assay; and (c2) providing a second list of second assay protocols, wherein the second list excludes any assay having a second level compatibility index value different from the second compatibility index value of the first assay.
In some embodiments, the second level compatibility can take into consideration any parameter that could prevent performance of two assay protocols concurrently at a single workstation. Such parameters are known to those of skill in the art, and can include, for example, physical parameters such as incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature, workstation time demands, and the like. Further, other parameters can include considerations such as regulatory classification, business considerations, and the like.
In some embodiments, the instrument prevents the concurrent performance of incompatible assay protocols within the same workstation when the first compatibility indexes are different. In some embodiments, the two discrete assay workflows are performed in the same workstation. In some embodiments, the instrument is prevented from concurrently performing assay protocols with different second compatibility index values. In some embodiments, two assay protocols have the same first level compatibility index value and have different second level compatibility index values. In some embodiments, the difference in the second level compatibility index values can comprise a business reason. In some embodiments, the difference in the second level compatibility index values can comprise a regulatory classification.
It will be appreciated that the two-level index described above is expandable from a two workflow system to larger numbers of workflows that are desired to run concurrently on an instrument, but may have constraints to run concurrently based on physical or business constraints. Thus, as illustrated in
Instruments and Systems
Also presented herein is a system for performing an automated assay, the system comprising an automated instrument comprising a first workstation and a second workstation, each of the first and second workstations configured to receive and processes a plurality of samples according to a plurality of different automated assay workflows, and supported by a single service resource. Each different automated assay workflow typically comprises an associated unique assay definition file or user-defined protocol file. The system also comprises a processor; a storage capacity; and a program for performing an automated assay, the program comprising instructions for determining whether two discrete assay workflows are compatible or incompatible with each other for concurrent processing on the automated instrument; and performing the discrete assay workflows concurrently on the instrument when the assays are compatible.
Automated instruments which can perform multiple assay protocols concurrently are known to those of skill in the art. Exemplary discussions of typical automated instruments for use with the methods provided herein can be found, for example, in U.S. patent application Ser. No. 12/173,023, filed Jul. 14, 2008, which is incorporated herein by reference in its entirety.
It will be appreciated that the methods and systems described herein can apply to instruments that comprise 2, 3, 4 or more workstations wherein at least 2 of the workstations are supported by a common service resource. For example, an instrument with 4 workstations and a single pipette head could still be compatibility controlled by the 2 index concept described herein.
As used herein, the terms storage capacity, storage device, storage and the like can refer to any medium, device or means of storage of information. Storage can include, but is not limited to, a disk drive device such as a hard drive, floppy disk, optical or magneto-optical disk, memory such as RAM or ROM chips, and any other medium used to record or store data. In some embodiments, a storage capacity is connected to a processor which sends information to be recorded on the storage capacity after it is acquired. In specific embodiments, data is acquired by a system and is recorded on a storage capacity. In other embodiments, data is acquired by a system and information is first processed and the processed information is recorded on a storage capacity.
The files and programs provided herein can be in any suitable programming language. In certain embodiments, the ADF utilizes XML as a mechanism for formatting files. Further, in certain embodiments, ADF utilizes Python as a scripting language to provide a mechanism for executing result logic using common technologies available on the instrument. It will be appreciated that any suitable file format and programming language can be utilized in the methods and systems provided herein. In certain embodiments, files can be encrypted to protect against the use of counterfeit reagents and to control specific parameter details on assay runs.
As used herein, an “input” can be, for example, data received from a keyboard, rollerball, mouse, voice recognition system or other device capable of transmitting information from a user to a computer. The input device can also be a touch screen associated with the display, in which case the user responds to prompts on the display by touching the screen. The user may enter textual information through the input device such as the keyboard or the touch-screen.
The invention is operational with numerous other general purpose or special purpose computing system environments or configurations. Examples of well-known computing systems, environments, and/or configurations that may be suitable for use with the invention include, but are not limited to, microcontrollers, personal computers, server computers, hand-held or laptop devices, multiprocessor systems, microprocessor-based systems, programmable consumer electronics, network PCs, minicomputers, mainframe computers, distributed computing environments that include any of the above systems or devices.
As used herein, “instructions” refer to computer-implemented steps for processing information in the system. Instructions can be implemented in software, firmware or hardware and include any type of programmed step undertaken by components of the system.
A “microprocessor” or “processor” may be any conventional general purpose single- or multi-core microprocessor such as a Pentium® processor, Intel® Core™, a 8051 processor, a MIPS® processor, or an ALPHA® processor. In addition, the microprocessor may be any conventional special purpose microprocessor such as a digital signal processor or a graphics processor. A “processor” may also refer to, but is not limited to, microcontrollers, field programmable gate arrays (FPGAs), application-specific integrated circuits (ASICs), complex programmable logic devices (CPLDs), programmable logic arrays (PLAs), microprocessors, or other similar processing devices.
The system is comprised of various modules as discussed in detail herein. As can be appreciated by one of ordinary skill in the art, each of the modules comprises various sub-routines, procedures, definitional statements and macros. Each of the modules are typically separately compiled and linked into a single executable program. Therefore, the following description of each of the modules is used for convenience to describe the functionality of the preferred system. Thus, the processes that are undergone by each of the modules may be arbitrarily redistributed to one of the other modules, combined together in a single module, or made available in, for example, a shareable dynamic link library.
Certain embodiments of the system may be used in connection with various operating systems such as SNOW LEOPARD®, iOS®, LINUX, UNIX or MICROSOFT WINDOWS®.
Certain embodiments of the system may be written in any conventional programming language such as assembly, C, C++, C#, BASIC, Pascal, or Java, and run under a conventional operating system.
In addition, the modules or instructions may be stored onto one or more programmable storage devices, such as FLASH drives, CD-ROMs, hard disks, and DVDs. One embodiment includes a programmable storage device having instructions stored thereon.
In some embodiments of the above system, the system further can comprise a device for reading identifying indicia on reagent packaging. It will be appreciated that any suitable device for reading identifying indicia can be used in the systems provided herein. Likewise, any suitable identifying indicia may be used that is compatible with the device on the instrument. Examples include bar codes, QR codes, RFID tags, color codes and the like. In typical embodiments, the device can be a bar code reader, and the identifying indicia can comprise a bar code. Example 4 below describes use of barcode labels to properly identify consumable reagents.
The methods and systems presented herein provide numerous advantages over existing approaches. For example, the use of an ADF by a manufacturer for the distribution of an assay protocols provides a mechanism for release of new or modified assay protocols on the instrument platform without requiring a coordinated instrument software update. By eliminating the need for instrument software revisions, this approach provides a more direct path towards release for the assay. Additionally, as needed, the manufacturer can modify compatibility between assay protocols to meet business or other needs without having to revise the instrument software.
Compatibility has traditionally been controlled using a table or other means that is maintained within the system and requires an update to expand menu. Using a two-level index does not require updating a table or any other means in the software to expand menu. Further, users do not need to have any specific knowledge about assay compatibility since the instrument software controls which assay protocols are available to mix in a single run.
An additional advantage of using an ADF is that barcode information in the ADF can be used to confirm that reagents are appropriately loaded onto the instrument, thereby preventing user error and the resulting loss of time and resources.
Having generally described this invention, a further understanding can be obtained by reference to certain specific examples which are provided herein for purposes of illustration only, and are not intended to be limiting.
This example demonstrates the process of assigning first- and second-level compatibility index values to a particular assay workflow or user defined protocol (UDP).
An automated sample processor and analysis instrument has the ability to run two discrete sample processing workflows, or racks, concurrently (run compatible). However, there are certain actions within a sample processing workflow that modified and still maintain compatibility (rack-compatible) as well as certain actions that render workflows incompatible on the instrument in the same run (incompatible). In addition to physical limitations, there may be business requirements to keep assay protocols from running together on an instrument.
To manage this range of performance demands, a two-level index was generated that identifies rack-compatible and run-compatible assay protocols. The index is assigned and maintained by the instrument manufacturer. The first level index implicates rack-compatibility, that is, assay protocols with the same index value can run in the same rack. The second level index implicates run-compatibility, that is, assay protocols which can be practiced in the second rack on an instrument relative to the assay in the first rack; by definition, rack-compatible assay protocols are also run-compatible. If assay protocols do not share a rack or run compatible index level, then the instrument is prevented from performing assay protocols on the instrument concurrently.
As shown in
Table 2 below illustrates several parameters that can influence compatibility. For example, in Table 2, cells with text in double-brackets highlight the parameters in Assays 4 and 5 that break compatibility with Guardrail Family A. Specifically, for Assay 4, aspiration height, lysis temperature, number of washes and magnet speed are outside of the limits for each parameter defined for Assays 1-3. Similarly, for Assay 5, aspiration height and lysis time are outside the limits for those parameters.
Table 2 thus illustrates that physical, temporal or other parameters need not be identical between assays in order to indicate compatibility. Rather, parameters can fall within a range which confers compatibility of, for example, a shared resource.
Table 3 below is an example of a table that assigns rack and run compatibility values for a set of assay protocols.
In Table 3, Families A, B, and C represent workflows that are not directly compatible with each other due to physical differences, such as incubation time, lysis time, reagent volume, reagent type, incubation temperature, lysis temperature or workstation time demands. In the diagram and the table, families A and B are run compatible, meaning that a first workstation could practice tests in Family A (not B), and that a second workstation could practice test in Family B (not A, if a B is selected for that workstation first). As shown in
In Table 3, three different Family A tests have a different compatibility index. While the workflows would indicate that they should be physically compatible, there could be other reasons that the manufacture chooses not to practice them on in the instrument at the same time. For example, when the manufacturer partners with a third party company, it may be desirable to prevent the user to run both manufacturer-supplied and third party-supplied tests on the instrument at the same time, even if the workflow of the test would allow it.
This example demonstrates identification of first-level and second-level compatibility between two assay protocols according to one embodiment. In the exemplary methods shown in
Assay Protocols on the Same Rack.
As described in the schematic shown in
Next, the system obtains the second-level (nm) compatibility index value for the selected first assay and compares the value to the second-level compatibility index value of all other remaining assay protocols. All assay protocols are identified which share a second-level compatibility index value with the selected assay, and any non-compatible assay protocols are excluded from further consideration. A list is then displayed which contains only first- and second-level compatible assay protocols. The user selects a second assay from that list, and when selection is complete, the system begins to perform the two assay protocols concurrently on the same rack, or on separate racks if desired.
Assay Protocols on Separate Racks.
Alternatively, the system can identify and run assay protocols on separate racks when they are not compatible to run together on the same rack. As described in the schematic shown in
No Other Compatible Assay Protocols.
In the event that the system does not identify other assay protocols which are either rack-compatible or run-compatible, the user can choose to perform a single assay protocol, using one or multiple samples, on the same or separate racks.
This example demonstrates the process of preparing a run worklist, including identification of assay protocols which can run concurrently in the same worklist, either on the same or on separate racks.
A user has a predetermined number of samples, each of which must be assigned an assay protocol. As shown in
If the first rack is full, the system allows the user to begin selecting assay protocols for the second rack. The system displays all protocols with the same level 2 (run compatible) index values as those in the first rack. The user then selects a protocol from that list of run compatible protocols. Once a first selection has been made for the second rack, the system auto-excludes all protocols with a different first-level compatibility index value, and displays a list of only those assay protocols that are not excluded. From the list of remaining protocols, the user selects another protocol from the list. This process repeats until all samples have been assigned an assay protocol, or until the second rack is full.
This example demonstrates the use of barcodes as identifying indicia for consumable packaging.
Consumable reagents provided by a supplier include a barcode label that the instrument can read. When an assay is created, the expected barcodes are identified in the ADF. When an instrument run commences, the instrument executes a catalog process, which confirms that the user loaded the proper consumables on the instrument deck. The barcode data stored in the ADF is used to provide this verification. If the barcode is not read, the instrument alerts the user and waits for assistance in acquiring the barcode. If the barcode is read, but does not match that expected for the assay test that was requested by the user, then the instrument alerts the user and waits for assistance in correcting the difference by, for example, swapping reagents. The use of barcodes on the reagents and barcode information in the ADF provides process assurance that the user has run the assay appropriately.
This example demonstrates the use of an ADF to accurately run assay protocols on an instrument.
The instrument first checks the ADF to determine the sample prep script needed to complete the run. The script data is then combined with the sample prep parameters defined in the ADF and the sample preparation process is initiated.
Upon completion of sample prep, the instrument again checks the ADF and executes the loadcartridge script identified in the ADF.
When loadcartridge completes, the instrument looks in the ADF to find out the fluorescence ratios needed to determine if the cartridge successfully loaded and compares those ratios with readings taken. If the instrument determines that the cartridge was successfully loaded, it then looks in the ADF to determine the PCR scripts to be used and PCR protocol necessary. Once these values are retrieved, the instrument begins the PCR process.
Upon completion of PCR, the instrument retrieves the parameters needed to run the data analysis algorithms from the ADF and executes the data analysis.
When data analysis completes the instrument combines the values returned from the data analysis engine with the result logic and result script identified in the ADF to derive a final call for that particular test.
Generation of UDP and Assignment of First-Level and Second-Level Compatibility Index Values
This example demonstrates the creation of a UDP and assignment of compatibility index values to the UDP to accurately run assay protocols on an instrument.
A user generates a new UDP by responding to prompts on a touch-screen display, selecting the assay type, assay parameters and reagents for the protocol. Factors that are selected include, for example, type of extraction kit and PCR parameters. Specifically, selecting from several available options, the user selects a particular reagent strip design, a particular of MM, and the specific process (extraction versus full process). The user elects to program a full process, and as such, the user can further define cycle times, temperatures and other parameters for PCR.
Following a process set forth in
Thus, going forward, when the user adds protocols to a run worklist, the user will be able to perform the new UDP concurrently with other ADFs or UDPs that have first and second level index values of 2 and 2, respectively.
It is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the embodiments belong. Although any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the embodiments, the preferred methods and materials are now described.
The term “comprising” as used herein is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.
It must be noted that as used herein and in the appended claims, the singular forms “a,” “and,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a method” includes a plurality of such methods and equivalents thereof known to those skilled in the art, and so forth.
All references cited herein including, but not limited to, published and unpublished applications, patents, and literature references, are incorporated herein by reference in their entirety and are hereby made a part of this specification. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
The steps of a method or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module may reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art. An exemplary storage medium may be coupled to the processor such the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium may be integral to the processor. The processor and the storage medium may reside in an ASIC. The ASIC may reside in a user terminal. In the alternative, the processor and the storage medium may reside as discrete components in a user terminal.
The present application claims priority to U.S. Provisional Application Ser. No. 61/594,867, entitled “EXTERNAL FILES FOR DISTRIBUTION OF MOLECULAR DIAGNOSTIC TESTS AND DETERMINATION OF COMPATIBILITY BETWEEN TESTS,” filed Feb. 3, 2012, the entire disclosure of which is herein incorporated by reference in its entirety
Number | Name | Date | Kind |
---|---|---|---|
1434314 | Raich | Oct 1922 | A |
1616419 | Wilson | Feb 1927 | A |
1733401 | Lovekin | Aug 1930 | A |
D189404 | Nicolle | Dec 1960 | S |
3050239 | Williams | Aug 1962 | A |
3528449 | Witte et al. | Sep 1970 | A |
3813316 | Chakrabarty et al. | May 1974 | A |
3905772 | Hartnett et al. | Sep 1975 | A |
3985649 | Eddelman | Oct 1976 | A |
4018089 | Dzula et al. | Apr 1977 | A |
4018652 | Lanham et al. | Apr 1977 | A |
4038192 | Serur | Jul 1977 | A |
4055395 | Honkawa et al. | Oct 1977 | A |
D249706 | Adamski | Sep 1978 | S |
4139005 | Dickey | Feb 1979 | A |
D252157 | Kronish et al. | Jun 1979 | S |
D252341 | Thomas | Jul 1979 | S |
D254687 | Fadler et al. | Apr 1980 | S |
4212744 | Oota | Jul 1980 | A |
D261033 | Armbruster | Sep 1981 | S |
D261173 | Armbruster | Oct 1981 | S |
4301412 | Hill et al. | Nov 1981 | A |
4439526 | Columbus | Mar 1984 | A |
4457329 | Werley et al. | Jul 1984 | A |
4466740 | Kano et al. | Aug 1984 | A |
4472357 | Levy et al. | Sep 1984 | A |
4504582 | Swann | Mar 1985 | A |
4522786 | Ebersole | Jun 1985 | A |
D279817 | Chen et al. | Jul 1985 | S |
D282208 | Lowry | Jan 1986 | S |
4599315 | Teraski et al. | Jul 1986 | A |
4612873 | Eberle | Sep 1986 | A |
4612959 | Costello | Sep 1986 | A |
D288478 | Carlson et al. | Feb 1987 | S |
4647432 | Wakatake | Mar 1987 | A |
4654127 | Baker et al. | Mar 1987 | A |
4673657 | Christian | Jun 1987 | A |
4678752 | Thorne et al. | Jul 1987 | A |
4683195 | Mullis et al. | Jul 1987 | A |
4683202 | Mullis | Jul 1987 | A |
4698302 | Whitehead et al. | Oct 1987 | A |
D292735 | Lovborg | Nov 1987 | S |
4720374 | Ramachandran | Jan 1988 | A |
4724207 | Hou et al. | Feb 1988 | A |
4798693 | Mase et al. | Jan 1989 | A |
4800022 | Leonard | Jan 1989 | A |
4827944 | Nugent | May 1989 | A |
4841786 | Schulz | Jun 1989 | A |
D302294 | Hillman | Jul 1989 | S |
4855110 | Marker et al. | Aug 1989 | A |
4871779 | Killat et al. | Oct 1989 | A |
4895650 | Wang | Jan 1990 | A |
4919829 | Gates et al. | Apr 1990 | A |
4921809 | Shiff et al. | May 1990 | A |
4935342 | Seligson et al. | Jun 1990 | A |
4946562 | Guruswamy | Aug 1990 | A |
4949742 | Rando et al. | Aug 1990 | A |
D310413 | Bigler et al. | Sep 1990 | S |
4963498 | Hillman | Oct 1990 | A |
4967950 | Legg et al. | Nov 1990 | A |
D312692 | Bradley | Dec 1990 | S |
4978502 | Dole et al. | Dec 1990 | A |
4978622 | Mishell et al. | Dec 1990 | A |
4989626 | Takagi et al. | Feb 1991 | A |
5001417 | Pumphrey et al. | Mar 1991 | A |
5004583 | Guruswamy et al. | Apr 1991 | A |
5048554 | Kremer | Sep 1991 | A |
5053199 | Keiser et al. | Oct 1991 | A |
5060823 | Perlman | Oct 1991 | A |
5061336 | Soane | Oct 1991 | A |
5064618 | Baker et al. | Nov 1991 | A |
5071531 | Soane | Dec 1991 | A |
5091328 | Miller | Feb 1992 | A |
D324426 | Fan et al. | Mar 1992 | S |
5096669 | Lauks et al. | Mar 1992 | A |
D325638 | Sloat et al. | Apr 1992 | S |
5126002 | Iwata et al. | Jun 1992 | A |
5126022 | Soane et al. | Jun 1992 | A |
D328135 | Fan et al. | Jul 1992 | S |
D328794 | Frenkel et al. | Aug 1992 | S |
5135627 | Soane | Aug 1992 | A |
5135872 | Pouletty et al. | Aug 1992 | A |
5147606 | Charlton et al. | Sep 1992 | A |
5169512 | Wiedenmann et al. | Dec 1992 | A |
D333522 | Gianino | Feb 1993 | S |
5186339 | Heissler | Feb 1993 | A |
5192507 | Taylor et al. | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5217694 | Gibler et al. | Jun 1993 | A |
5223226 | Whittmer et al. | Jun 1993 | A |
5229297 | Schnipelsky | Jul 1993 | A |
D338275 | Fischer et al. | Aug 1993 | S |
5250263 | Manz | Oct 1993 | A |
5252743 | Barrett et al. | Oct 1993 | A |
5256376 | Callan et al. | Oct 1993 | A |
5273716 | Northrup et al. | Dec 1993 | A |
5275787 | Yuguchi et al. | Jan 1994 | A |
5282950 | Dietze et al. | Feb 1994 | A |
5296375 | Kricka et al. | Mar 1994 | A |
5304477 | Nagoh et al. | Apr 1994 | A |
5304487 | Wilding et al. | Apr 1994 | A |
D347478 | Pinkney | May 1994 | S |
5311896 | Kaartinen et al. | May 1994 | A |
5311996 | Duffy et al. | May 1994 | A |
5316727 | Suzuki et al. | May 1994 | A |
5327038 | Culp | Jul 1994 | A |
5339486 | Persic, Jr. | Aug 1994 | A |
D351475 | Gerber | Oct 1994 | S |
D351913 | Hieb et al. | Oct 1994 | S |
5364591 | Green et al. | Nov 1994 | A |
5372946 | Cusak et al. | Dec 1994 | A |
5374395 | Robinson | Dec 1994 | A |
5389339 | Petschek et al. | Feb 1995 | A |
D356232 | Armstrong et al. | Mar 1995 | S |
5397709 | Berndt | Mar 1995 | A |
5401465 | Smethers et al. | Mar 1995 | A |
5411708 | Moscetta et al. | May 1995 | A |
5414245 | Hackleman | May 1995 | A |
5415839 | Zaun et al. | May 1995 | A |
5416000 | Allen et al. | May 1995 | A |
5422271 | Chen et al. | Jun 1995 | A |
5422284 | Lau | Jun 1995 | A |
5427946 | Kricka et al. | Jun 1995 | A |
5443791 | Cathcart et al. | Aug 1995 | A |
5474796 | Brennan | Dec 1995 | A |
5475487 | Mariella, Jr. et al. | Dec 1995 | A |
D366116 | Biskupski | Jan 1996 | S |
5486335 | Wilding et al. | Jan 1996 | A |
5494639 | Grzegorzewski | Feb 1996 | A |
5498392 | Wilding et al. | Mar 1996 | A |
5503803 | Brown | Apr 1996 | A |
5516410 | Schneider et al. | May 1996 | A |
5519635 | Miyake et al. | May 1996 | A |
5529677 | Schneider et al. | Jun 1996 | A |
5559432 | Logue | Sep 1996 | A |
5565171 | Dovichi et al. | Oct 1996 | A |
5569364 | Hooper et al. | Oct 1996 | A |
5578270 | Reichler et al. | Nov 1996 | A |
5578818 | Kain et al. | Nov 1996 | A |
5579928 | Anukwuem | Dec 1996 | A |
5580523 | Bard | Dec 1996 | A |
5582884 | Ball et al. | Dec 1996 | A |
5582988 | Backus et al. | Dec 1996 | A |
5585069 | Zanucchi et al. | Dec 1996 | A |
5585089 | Queen et al. | Dec 1996 | A |
5585242 | Bouma et al. | Dec 1996 | A |
5587128 | Wilding et al. | Dec 1996 | A |
5589136 | Northrup et al. | Dec 1996 | A |
5593838 | Zanzucchi et al. | Jan 1997 | A |
5595708 | Berndt | Jan 1997 | A |
5599432 | Manz et al. | Feb 1997 | A |
5599503 | Manz et al. | Feb 1997 | A |
5599667 | Arnold, Jr. et al. | Feb 1997 | A |
5601727 | Bormann et al. | Feb 1997 | A |
5603351 | Cherukuri et al. | Feb 1997 | A |
5605662 | Heller et al. | Feb 1997 | A |
5609910 | Hackleman | Mar 1997 | A |
D378782 | LaBarbera et al. | Apr 1997 | S |
5628890 | Carter et al. | May 1997 | A |
5630920 | Friese et al. | May 1997 | A |
5631337 | Sassi et al. | May 1997 | A |
5632876 | Zanzucchi et al. | May 1997 | A |
5632957 | Heller et al. | May 1997 | A |
5635358 | Wilding et al. | Jun 1997 | A |
5637469 | Wilding et al. | Jun 1997 | A |
5639423 | Northrup et al. | Jun 1997 | A |
5639428 | Cottingham | Jun 1997 | A |
5643738 | Zanzucchi et al. | Jul 1997 | A |
5645801 | Bouma et al. | Jul 1997 | A |
5646039 | Northrup et al. | Jul 1997 | A |
5646049 | Tayi | Jul 1997 | A |
5647994 | Tuunanen et al. | Jul 1997 | A |
5651839 | Rauf | Jul 1997 | A |
5652141 | Henco et al. | Jul 1997 | A |
5652149 | Mileaf et al. | Jul 1997 | A |
D382346 | Buhler et al. | Aug 1997 | S |
D382647 | Staples et al. | Aug 1997 | S |
5654141 | Mariani et al. | Aug 1997 | A |
5658515 | Lee et al. | Aug 1997 | A |
5667976 | Van Ness et al. | Sep 1997 | A |
5671303 | Shieh et al. | Sep 1997 | A |
5674394 | Whitmore | Oct 1997 | A |
5674742 | Northrup et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5681529 | Taguchi et al. | Oct 1997 | A |
5683657 | Mian | Nov 1997 | A |
5683659 | Hovatter | Nov 1997 | A |
5699157 | Parce | Dec 1997 | A |
5700637 | Southern | Dec 1997 | A |
5705813 | Apffel et al. | Jan 1998 | A |
5721136 | Finney et al. | Feb 1998 | A |
5725831 | Reichler et al. | Mar 1998 | A |
5726026 | Wilding et al. | Mar 1998 | A |
5726404 | Brody | Mar 1998 | A |
5726944 | Pelley et al. | Mar 1998 | A |
5731212 | Gavin et al. | Mar 1998 | A |
5744366 | Kricka et al. | Apr 1998 | A |
5746978 | Bienhaus et al. | May 1998 | A |
5747666 | Willis | May 1998 | A |
5750015 | Soane et al. | May 1998 | A |
5755942 | Zanzucchi et al. | May 1998 | A |
5762874 | Seaton et al. | Jun 1998 | A |
5763262 | Wong et al. | Jun 1998 | A |
5770029 | Nelson et al. | Jun 1998 | A |
5770388 | Vorpahl | Jun 1998 | A |
5772966 | Maracas et al. | Jun 1998 | A |
5779868 | Parce et al. | Jul 1998 | A |
5783148 | Cottingham et al. | Jul 1998 | A |
5787032 | Heller et al. | Jul 1998 | A |
5788814 | Sun et al. | Aug 1998 | A |
5800600 | Lima-Marques et al. | Sep 1998 | A |
5800690 | Chow et al. | Sep 1998 | A |
5804436 | Okun et al. | Sep 1998 | A |
D399959 | Prokop et al. | Oct 1998 | S |
5819749 | Lee et al. | Oct 1998 | A |
5827481 | Bente et al. | Oct 1998 | A |
5842106 | Thaler et al. | Nov 1998 | A |
5842787 | Kopf-Sill et al. | Dec 1998 | A |
5846396 | Zanzucchi et al. | Dec 1998 | A |
5846493 | Bankier et al. | Dec 1998 | A |
5849208 | Hayes et al. | Dec 1998 | A |
5849486 | Heller et al. | Dec 1998 | A |
5849489 | Heller | Dec 1998 | A |
5849598 | Wilson et al. | Dec 1998 | A |
5852495 | Parce | Dec 1998 | A |
5856174 | Lipshutz et al. | Jan 1999 | A |
5858187 | Ramsey et al. | Jan 1999 | A |
5858188 | Soane et al. | Jan 1999 | A |
5863502 | Southgate et al. | Jan 1999 | A |
5863708 | Zanzucchi et al. | Jan 1999 | A |
5863801 | Southgate et al. | Jan 1999 | A |
5866345 | Wilding et al. | Feb 1999 | A |
5869004 | Parce et al. | Feb 1999 | A |
5869244 | Martin et al. | Feb 1999 | A |
5872010 | Karger et al. | Feb 1999 | A |
5872623 | Stabile et al. | Feb 1999 | A |
5874046 | Megerle | Feb 1999 | A |
5876675 | Kennedy | Mar 1999 | A |
5880071 | Parce et al. | Mar 1999 | A |
5882465 | McReynolds | Mar 1999 | A |
5883211 | Sassi et al. | Mar 1999 | A |
5885432 | Hooper et al. | Mar 1999 | A |
5885470 | Parce et al. | Mar 1999 | A |
5895762 | Greenfield et al. | Apr 1999 | A |
5900130 | Benregnu et al. | May 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5912124 | Kumar | Jun 1999 | A |
5912134 | Shartle | Jun 1999 | A |
5914229 | Loewy | Jun 1999 | A |
5916522 | Boyd et al. | Jun 1999 | A |
5916776 | Kumar | Jun 1999 | A |
5919646 | Okun et al. | Jul 1999 | A |
5919711 | Boyd et al. | Jul 1999 | A |
5922591 | Anderson et al. | Jul 1999 | A |
5927547 | Papen et al. | Jul 1999 | A |
5928161 | Krulevitch et al. | Jul 1999 | A |
5928880 | Wilding et al. | Jul 1999 | A |
5929208 | Heller et al. | Jul 1999 | A |
D413391 | Lapeus et al. | Aug 1999 | S |
5932799 | Moles | Aug 1999 | A |
5935401 | Amigo | Aug 1999 | A |
5939291 | Loewy et al. | Aug 1999 | A |
5939312 | Baier et al. | Aug 1999 | A |
5942443 | Parce et al. | Aug 1999 | A |
5944717 | Lee et al. | Aug 1999 | A |
D413677 | Dumitrescu et al. | Sep 1999 | S |
D414271 | Mendoza | Sep 1999 | S |
5948227 | Dubrow | Sep 1999 | A |
5948363 | Gaillard | Sep 1999 | A |
5948673 | Cottingham | Sep 1999 | A |
5955028 | Chow | Sep 1999 | A |
5955029 | Wilding et al. | Sep 1999 | A |
5957579 | Kopf-Sill et al. | Sep 1999 | A |
5958203 | Parce et al. | Sep 1999 | A |
5958349 | Petersen et al. | Sep 1999 | A |
5958694 | Nikiforov | Sep 1999 | A |
5959221 | Boyd et al. | Sep 1999 | A |
5959291 | Jensen | Sep 1999 | A |
5935522 | Swerdlow et al. | Oct 1999 | A |
5964995 | Nikiforov et al. | Oct 1999 | A |
5964997 | McBride | Oct 1999 | A |
5965001 | Chow et al. | Oct 1999 | A |
5965410 | Chow et al. | Oct 1999 | A |
5965886 | Sauer et al. | Oct 1999 | A |
5968745 | Thorp et al. | Oct 1999 | A |
5972187 | Parce et al. | Oct 1999 | A |
5973138 | Collis | Oct 1999 | A |
D417009 | Boyd | Nov 1999 | S |
5976336 | Dubrow et al. | Nov 1999 | A |
5980704 | Cherukuri et al. | Nov 1999 | A |
5980719 | Cherukuri et al. | Nov 1999 | A |
5981735 | Thatcher et al. | Nov 1999 | A |
5985651 | Hunicke-Smith | Nov 1999 | A |
5989402 | Chow et al. | Nov 1999 | A |
5992820 | Fare et al. | Nov 1999 | A |
5993611 | Moroney, III et al. | Nov 1999 | A |
5993750 | Ghosh et al. | Nov 1999 | A |
5997708 | Craig | Dec 1999 | A |
6001229 | Ramsey | Dec 1999 | A |
6001231 | Kopf-Sill | Dec 1999 | A |
6001307 | Naka et al. | Dec 1999 | A |
6004450 | Northrup et al. | Dec 1999 | A |
6004515 | Parce et al. | Dec 1999 | A |
6007690 | Nelson et al. | Dec 1999 | A |
6010607 | Ramsey | Jan 2000 | A |
6010608 | Ramsey | Jan 2000 | A |
6010627 | Hood, III | Jan 2000 | A |
6012902 | Parce | Jan 2000 | A |
D420747 | Dumitrescu et al. | Feb 2000 | S |
D421130 | Cohen et al. | Feb 2000 | S |
6024920 | Cunanan | Feb 2000 | A |
D421653 | Purcell | Mar 2000 | S |
6033546 | Ramsey | Mar 2000 | A |
6033880 | Haff et al. | Mar 2000 | A |
6043080 | Lipshutz et al. | Mar 2000 | A |
6046056 | Parce et al. | Apr 2000 | A |
6048734 | Burns et al. | Apr 2000 | A |
6054034 | Soane et al. | Apr 2000 | A |
6054277 | Furcht et al. | Apr 2000 | A |
6056860 | Amigo et al. | May 2000 | A |
6057149 | Burns et al. | May 2000 | A |
6062261 | Jacobson et al. | May 2000 | A |
6063341 | Fassbind et al. | May 2000 | A |
6063589 | Kellogg et al. | May 2000 | A |
6068751 | Neukermans | May 2000 | A |
6068752 | Dubrow et al. | May 2000 | A |
6071478 | Chow | Jun 2000 | A |
6074725 | Kennedy | Jun 2000 | A |
6074827 | Nelson et al. | Jun 2000 | A |
D428497 | Lapeus et al. | Jul 2000 | S |
6086740 | Kennedy | Jul 2000 | A |
6096509 | Okun et al. | Aug 2000 | A |
6100541 | Nagle et al. | Aug 2000 | A |
6102897 | Lang | Aug 2000 | A |
6103537 | Ullman et al. | Aug 2000 | A |
6106685 | McBride et al. | Aug 2000 | A |
6110343 | Ramsey et al. | Aug 2000 | A |
6117398 | Bienhaus et al. | Sep 2000 | A |
6123205 | Dumitrescu et al. | Sep 2000 | A |
6123798 | Gandhi et al. | Sep 2000 | A |
6130098 | Handique et al. | Oct 2000 | A |
6132580 | Mathies et al. | Oct 2000 | A |
6132684 | Marino | Oct 2000 | A |
6133436 | Koster et al. | Oct 2000 | A |
D433759 | Mathis et al. | Nov 2000 | S |
6143250 | Tajima | Nov 2000 | A |
6143547 | Hsu | Nov 2000 | A |
6149787 | Chow et al. | Nov 2000 | A |
6149872 | Mack et al. | Nov 2000 | A |
6156199 | Zuk, Jr. | Dec 2000 | A |
6158269 | Dorenkott et al. | Dec 2000 | A |
6167910 | Chow | Jan 2001 | B1 |
6168948 | Anderson et al. | Jan 2001 | B1 |
6171850 | Nagle et al. | Jan 2001 | B1 |
6174675 | Chow et al. | Jan 2001 | B1 |
6180950 | Olsen | Jan 2001 | B1 |
D438311 | Yamanishi et al. | Feb 2001 | S |
6190619 | Kilcoin et al. | Feb 2001 | B1 |
6194563 | Cruickshank | Feb 2001 | B1 |
D438632 | Miller | Mar 2001 | S |
D438633 | Miller | Mar 2001 | S |
D439673 | Brophy et al. | Mar 2001 | S |
6197595 | Anderson et al. | Mar 2001 | B1 |
6211989 | Wulf et al. | Apr 2001 | B1 |
6213151 | Jacobson et al. | Apr 2001 | B1 |
6221600 | MacLeod et al. | Apr 2001 | B1 |
6228635 | Armstrong et al. | May 2001 | B1 |
6232072 | Fisher | May 2001 | B1 |
6235175 | Dubrow et al. | May 2001 | B1 |
6235313 | Mathiowitz et al. | May 2001 | B1 |
6235471 | Knapp et al. | May 2001 | B1 |
6236456 | Giebeler et al. | May 2001 | B1 |
6236581 | Foss et al. | May 2001 | B1 |
6238626 | Higuchi et al. | May 2001 | B1 |
6251343 | Dubrow et al. | Jun 2001 | B1 |
6254826 | Acosta et al. | Jul 2001 | B1 |
6259635 | Khouri et al. | Jul 2001 | B1 |
6261431 | Mathies et al. | Jul 2001 | B1 |
6267858 | Parce et al. | Jul 2001 | B1 |
D446306 | Ochi et al. | Aug 2001 | S |
6271021 | Burns et al. | Aug 2001 | B1 |
6274089 | Chow et al. | Aug 2001 | B1 |
6280967 | Ransom et al. | Aug 2001 | B1 |
6281008 | Komai et al. | Aug 2001 | B1 |
6284113 | Bjornson et al. | Sep 2001 | B1 |
6284470 | Bitner et al. | Sep 2001 | B1 |
6287254 | Dodds | Sep 2001 | B1 |
6287774 | Kikiforov | Sep 2001 | B1 |
6291248 | Haj-Ahmad | Sep 2001 | B1 |
6294063 | Becker et al. | Sep 2001 | B1 |
6300124 | Blumenfeld et al. | Oct 2001 | B1 |
6302134 | Kellogg et al. | Oct 2001 | B1 |
6302304 | Spencer | Oct 2001 | B1 |
6303343 | Kopf-sill | Oct 2001 | B1 |
6306273 | Wainright et al. | Oct 2001 | B1 |
6306590 | Mehta et al. | Oct 2001 | B1 |
6310199 | Smith et al. | Oct 2001 | B1 |
6316774 | Giebeler et al. | Nov 2001 | B1 |
6319469 | Mien et al. | Nov 2001 | B1 |
6319474 | Krulevitch et al. | Nov 2001 | B1 |
6322683 | Wolk et al. | Nov 2001 | B1 |
6326083 | Yang et al. | Dec 2001 | B1 |
6326147 | Oldham et al. | Dec 2001 | B1 |
6326211 | Anderson et al. | Dec 2001 | B1 |
6334980 | Hayes et al. | Jan 2002 | B1 |
6337435 | Chu et al. | Jan 2002 | B1 |
6353475 | Jensen et al. | Mar 2002 | B1 |
6358387 | Kopf-sill et al. | Mar 2002 | B1 |
6366924 | Parce | Apr 2002 | B1 |
6368561 | Rutishauser et al. | Apr 2002 | B1 |
6368871 | Christel et al. | Apr 2002 | B1 |
6370206 | Schenk | Apr 2002 | B1 |
6375185 | Lin | Apr 2002 | B1 |
6375901 | Robotti et al. | Apr 2002 | B1 |
6379884 | Wada et al. | Apr 2002 | B2 |
6379929 | Burns et al. | Apr 2002 | B1 |
6379974 | Parce et al. | Apr 2002 | B1 |
6382254 | Yang et al. | May 2002 | B1 |
6391541 | Petersen et al. | May 2002 | B1 |
6391623 | Besemer et al. | May 2002 | B1 |
6395161 | Schneider et al. | May 2002 | B1 |
6398956 | Coville et al. | Jun 2002 | B1 |
6399025 | Chow | Jun 2002 | B1 |
6399389 | Parce et al. | Jun 2002 | B1 |
6399952 | Maher et al. | Jun 2002 | B1 |
6401552 | Elkins | Jun 2002 | B1 |
6403338 | Knapp et al. | Jun 2002 | B1 |
6408878 | Unger et al. | Jun 2002 | B2 |
6413401 | Chow et al. | Jul 2002 | B1 |
6416642 | Alajoki et al. | Jul 2002 | B1 |
6420143 | Kopf-sill | Jul 2002 | B1 |
6425972 | McReynolds | Jul 2002 | B1 |
D461906 | Pham | Aug 2002 | S |
6428987 | Franzen | Aug 2002 | B2 |
6430512 | Gallagher | Aug 2002 | B1 |
6432366 | Ruediger et al. | Aug 2002 | B2 |
6440725 | Pourahmadi et al. | Aug 2002 | B1 |
D463031 | Slomski et al. | Sep 2002 | S |
6444461 | Knapp et al. | Sep 2002 | B1 |
6447661 | Chow et al. | Sep 2002 | B1 |
6447727 | Parce et al. | Sep 2002 | B1 |
6448064 | Vo-Dinh et al. | Sep 2002 | B1 |
6453928 | Kaplan et al. | Sep 2002 | B1 |
6458259 | Parce et al. | Oct 2002 | B1 |
6465257 | Parce et al. | Oct 2002 | B1 |
6468761 | Yang et al. | Oct 2002 | B2 |
6472141 | Nikiforov | Oct 2002 | B2 |
D466219 | Wynschenk et al. | Nov 2002 | S |
6475364 | Dubrow et al. | Nov 2002 | B1 |
D467348 | McMichael et al. | Dec 2002 | S |
D467349 | Niedbala et al. | Dec 2002 | S |
6488897 | Dubrow et al. | Dec 2002 | B2 |
6495104 | Unno et al. | Dec 2002 | B1 |
6498497 | Chow et al. | Dec 2002 | B1 |
6500323 | Chow et al. | Dec 2002 | B1 |
6500390 | Boulton et al. | Dec 2002 | B1 |
D468437 | McMenamy et al. | Jan 2003 | S |
6506609 | Wada et al. | Jan 2003 | B1 |
6509186 | Zou et al. | Jan 2003 | B1 |
6509193 | Tajima | Jan 2003 | B1 |
6511853 | Kopf-sill et al. | Jan 2003 | B1 |
D470595 | Crisanti et al. | Feb 2003 | S |
6515753 | Maher | Feb 2003 | B2 |
6517783 | Horner et al. | Feb 2003 | B2 |
6520197 | Deshmukh et al. | Feb 2003 | B2 |
6521181 | Northrup et al. | Feb 2003 | B1 |
6521188 | Webster | Feb 2003 | B1 |
6524456 | Ramsey et al. | Feb 2003 | B1 |
6524532 | Northrup | Feb 2003 | B1 |
6524790 | Kopf-sill et al. | Feb 2003 | B1 |
D472324 | Rumore et al. | Mar 2003 | S |
6534295 | Tai et al. | Mar 2003 | B2 |
6537432 | Schneider et al. | Mar 2003 | B1 |
6537771 | Farinas et al. | Mar 2003 | B1 |
6540896 | Manz et al. | Apr 2003 | B1 |
6544734 | Briscoe et al. | Apr 2003 | B1 |
6547942 | Parce et al. | Apr 2003 | B1 |
6555389 | Ullman et al. | Apr 2003 | B1 |
6556923 | Gallagher et al. | Apr 2003 | B2 |
D474279 | Mayer et al. | May 2003 | S |
D474280 | Niedbala et al. | May 2003 | S |
6558916 | Veerapandian et al. | May 2003 | B2 |
6558945 | Kao | May 2003 | B1 |
6565815 | Chang et al. | May 2003 | B1 |
6569607 | McReynolds | May 2003 | B2 |
6572830 | Burdon et al. | Jun 2003 | B1 |
6575188 | Parunak | Jun 2003 | B2 |
6576459 | Miles et al. | Jun 2003 | B2 |
6579453 | Bächler et al. | Jun 2003 | B1 |
6589729 | Chan et al. | Jul 2003 | B2 |
6592821 | Wada et al. | Jul 2003 | B1 |
6597450 | Andrews et al. | Jul 2003 | B1 |
6602474 | Tajima | Aug 2003 | B1 |
6613211 | Mccormick et al. | Sep 2003 | B1 |
6613512 | Kopf-sill et al. | Sep 2003 | B1 |
6613580 | Chow et al. | Sep 2003 | B1 |
6613581 | Wada et al. | Sep 2003 | B1 |
6614030 | Maher et al. | Sep 2003 | B2 |
6620625 | Wolk et al. | Sep 2003 | B2 |
6623860 | Hu et al. | Sep 2003 | B2 |
6627406 | Singh et al. | Sep 2003 | B1 |
D480814 | Lafferty et al. | Oct 2003 | S |
6632655 | Mehta et al. | Oct 2003 | B1 |
6633785 | Kasahara et al. | Oct 2003 | B1 |
D482796 | Oyama et al. | Nov 2003 | S |
6640981 | Lafond et al. | Nov 2003 | B2 |
6649358 | Parce et al. | Nov 2003 | B1 |
6664104 | Pourahmadi et al. | Dec 2003 | B2 |
6669831 | Chow et al. | Dec 2003 | B2 |
6670153 | Stern | Dec 2003 | B2 |
D484989 | Gebrian | Jan 2004 | S |
6672458 | Hansen et al. | Jan 2004 | B2 |
6681616 | Spaid et al. | Jan 2004 | B2 |
6681788 | Parce et al. | Jan 2004 | B2 |
6685813 | Williams et al. | Feb 2004 | B2 |
6692700 | Handique | Feb 2004 | B2 |
6695009 | Chien et al. | Feb 2004 | B2 |
6699713 | Benett et al. | Mar 2004 | B2 |
6706519 | Kellogg et al. | Mar 2004 | B1 |
6720148 | Nikiforov | Apr 2004 | B1 |
6730206 | Ricco et al. | May 2004 | B2 |
6733645 | Chow | May 2004 | B1 |
6734401 | Bedingham et al. | May 2004 | B2 |
6737026 | Bergh et al. | May 2004 | B1 |
6740518 | Duong et al. | May 2004 | B1 |
D491272 | Alden et al. | Jun 2004 | S |
D491273 | Biegler et al. | Jun 2004 | S |
D491276 | Langille | Jun 2004 | S |
6750661 | Brooks et al. | Jun 2004 | B2 |
6752966 | Chazan | Jun 2004 | B1 |
6756019 | Dubrow et al. | Jun 2004 | B1 |
6762049 | Zou et al. | Jul 2004 | B2 |
6764859 | Kreuwel et al. | Jul 2004 | B1 |
6766817 | Dias da Silva | Jul 2004 | B2 |
6773567 | Wolk | Aug 2004 | B1 |
6777184 | Nikiforov et al. | Aug 2004 | B2 |
6783962 | Olander et al. | Aug 2004 | B1 |
D495805 | Lea et al. | Sep 2004 | S |
6787015 | Lackritz et al. | Sep 2004 | B2 |
6787016 | Tan et al. | Sep 2004 | B2 |
6787111 | Roach et al. | Sep 2004 | B2 |
6790328 | Jacobson et al. | Sep 2004 | B2 |
6790330 | Gascoyne et al. | Sep 2004 | B2 |
6811668 | Berndt et al. | Nov 2004 | B1 |
6818113 | Williams et al. | Nov 2004 | B2 |
6819027 | Saraf | Nov 2004 | B2 |
6824663 | Boone | Nov 2004 | B1 |
D499813 | Wu | Dec 2004 | S |
D500142 | Crisanti et al. | Dec 2004 | S |
D500363 | Fanning et al. | Dec 2004 | S |
6827831 | Chow et al. | Dec 2004 | B1 |
6827906 | Bjornson et al. | Dec 2004 | B1 |
6838156 | Neyer et al. | Jan 2005 | B1 |
6838680 | Maher et al. | Jan 2005 | B2 |
6852287 | Ganesan | Feb 2005 | B2 |
6858185 | Kopf-sill et al. | Feb 2005 | B1 |
6859698 | Schmeisser | Feb 2005 | B2 |
6861035 | Pham et al. | Mar 2005 | B2 |
6878540 | Pourahmadi et al. | Apr 2005 | B2 |
6878755 | Singh et al. | Apr 2005 | B2 |
6884628 | Hubbell et al. | Apr 2005 | B2 |
6887693 | McMillan et al. | May 2005 | B2 |
6893879 | Petersen et al. | May 2005 | B2 |
6900889 | Bjornson et al. | May 2005 | B2 |
6905583 | Wainright et al. | Jun 2005 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6906797 | Kao et al. | Jun 2005 | B1 |
6908594 | Schaevitz et al. | Jun 2005 | B1 |
6911183 | Handique et al. | Jun 2005 | B1 |
6914137 | Baker | Jul 2005 | B2 |
6915679 | Chien et al. | Jul 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
D508999 | Fanning et al. | Aug 2005 | S |
6939451 | Zhao et al. | Sep 2005 | B2 |
6940598 | Christel et al. | Sep 2005 | B2 |
6942771 | Kayyem | Sep 2005 | B1 |
6951632 | Unger et al. | Oct 2005 | B2 |
6958392 | Fomovskaia et al. | Oct 2005 | B2 |
D512155 | Matsumoto | Nov 2005 | S |
6964747 | Banerjee et al. | Nov 2005 | B2 |
6977163 | Mehta | Dec 2005 | B1 |
6979424 | Northrup et al. | Dec 2005 | B2 |
6984516 | Briscoe et al. | Jan 2006 | B2 |
D515707 | Sinohara et al. | Feb 2006 | S |
D516221 | Wohlstadter et al. | Feb 2006 | S |
7001853 | Brown et al. | Feb 2006 | B1 |
7004184 | Handique et al. | Feb 2006 | B2 |
D517554 | Yanagisawa et al. | Mar 2006 | S |
7010391 | Handique et al. | Mar 2006 | B2 |
7023007 | Gallagher | Apr 2006 | B2 |
7024281 | Unno | Apr 2006 | B1 |
7036667 | Greenstein et al. | May 2006 | B2 |
7037416 | Parce et al. | May 2006 | B2 |
7038472 | Chien | May 2006 | B1 |
7039527 | Tripathi et al. | May 2006 | B2 |
7040144 | Spaid et al. | May 2006 | B2 |
7049558 | Baer et al. | May 2006 | B2 |
D523153 | Akashi et al. | Jun 2006 | S |
7055695 | Greenstein et al. | Jun 2006 | B2 |
7060171 | Nikiforov et al. | Jun 2006 | B1 |
7066586 | Dias da Silva | Jun 2006 | B2 |
7069952 | McReynolds et al. | Jul 2006 | B1 |
7072036 | Jones et al. | Jul 2006 | B2 |
7099778 | Chien | Aug 2006 | B2 |
D528215 | Malmsater | Sep 2006 | S |
7101467 | Spaid | Sep 2006 | B2 |
7105304 | Nikiforov et al. | Sep 2006 | B1 |
D531321 | Godfrey et al. | Oct 2006 | S |
7118910 | Unger et al. | Oct 2006 | B2 |
7122799 | Hsieh et al. | Oct 2006 | B2 |
7135144 | Christel et al. | Nov 2006 | B2 |
7138032 | Gandhi et al. | Nov 2006 | B2 |
D534280 | Gomm et al. | Dec 2006 | S |
7148043 | Kordunsky et al. | Dec 2006 | B2 |
7150814 | Parce et al. | Dec 2006 | B1 |
7150999 | Shuck | Dec 2006 | B1 |
D535403 | Isozaki et al. | Jan 2007 | S |
7160423 | Chien et al. | Jan 2007 | B2 |
7161356 | Chien | Jan 2007 | B1 |
7169277 | Ausserer et al. | Jan 2007 | B2 |
7169601 | Northrup et al. | Jan 2007 | B1 |
7169618 | Skould | Jan 2007 | B2 |
D537951 | Okamoto et al. | Mar 2007 | S |
D538436 | Patadia et al. | Mar 2007 | S |
7188001 | Young et al. | Mar 2007 | B2 |
7192557 | Wu et al. | Mar 2007 | B2 |
7195986 | Bousse et al. | Mar 2007 | B1 |
7205154 | Corson | Apr 2007 | B2 |
7208125 | Dong | Apr 2007 | B1 |
7235406 | Woudenberg et al. | Jun 2007 | B1 |
7247274 | Chow | Jul 2007 | B1 |
D548841 | Brownell et al. | Aug 2007 | S |
D549827 | Maeno et al. | Aug 2007 | S |
7252928 | Hafeman et al. | Aug 2007 | B1 |
7255833 | Chang et al. | Aug 2007 | B2 |
7270786 | Parunak et al. | Sep 2007 | B2 |
D554069 | Bolotin et al. | Oct 2007 | S |
D554070 | Bolotin et al. | Oct 2007 | S |
7276208 | Sevigny et al. | Oct 2007 | B2 |
7276330 | Chow et al. | Oct 2007 | B2 |
7288228 | Lefebvre | Oct 2007 | B2 |
7297313 | Northrup et al. | Nov 2007 | B1 |
D556914 | Okamoto et al. | Dec 2007 | S |
7303727 | Dubrow et al. | Dec 2007 | B1 |
D559995 | Handique et al. | Jan 2008 | S |
7315376 | Bickmore et al. | Jan 2008 | B2 |
7323140 | Handique et al. | Jan 2008 | B2 |
7332130 | Handique | Feb 2008 | B2 |
7338760 | Gong et al. | Mar 2008 | B2 |
D566291 | Parunak et al. | Apr 2008 | S |
7351377 | Chazan et al. | Apr 2008 | B2 |
D569526 | Duffy et al. | May 2008 | S |
7374949 | Kuriger | May 2008 | B2 |
7390460 | Osawa et al. | Jun 2008 | B2 |
7419784 | Dubrow et al. | Sep 2008 | B2 |
7422669 | Jacobson et al. | Sep 2008 | B2 |
7440684 | Spaid et al. | Oct 2008 | B2 |
7476313 | Siddiqi | Jan 2009 | B2 |
7480042 | Phillips et al. | Jan 2009 | B1 |
7494577 | Williams et al. | Feb 2009 | B2 |
7494770 | Wilding et al. | Feb 2009 | B2 |
7514046 | Kechagia et al. | Apr 2009 | B2 |
7518726 | Rulison et al. | Apr 2009 | B2 |
7521186 | Burd Mehta | Apr 2009 | B2 |
7527769 | Bunch et al. | May 2009 | B2 |
D595423 | Johansson et al. | Jun 2009 | S |
7553671 | Sinclair et al. | Jun 2009 | B2 |
D596312 | Giraud et al. | Jul 2009 | S |
D598566 | Allaer | Aug 2009 | S |
7578976 | Northrup et al. | Aug 2009 | B1 |
D599234 | Ito | Sep 2009 | S |
7595197 | Brasseur | Sep 2009 | B2 |
7604938 | Takahashi et al. | Oct 2009 | B2 |
7622296 | Joseph et al. | Nov 2009 | B2 |
7628902 | Knowlton et al. | Dec 2009 | B2 |
7633606 | Northrup et al. | Dec 2009 | B2 |
7635588 | King et al. | Dec 2009 | B2 |
7645581 | Knapp et al. | Jan 2010 | B2 |
7670559 | Chien et al. | Mar 2010 | B2 |
7674431 | Ganesan | Mar 2010 | B2 |
7689022 | Weiner et al. | Mar 2010 | B2 |
7704735 | Facer et al. | Apr 2010 | B2 |
7705739 | Northrup et al. | Apr 2010 | B2 |
7723123 | Murphy et al. | May 2010 | B1 |
D618820 | Wilson et al. | Jun 2010 | S |
7727371 | Kennedy et al. | Jun 2010 | B2 |
7727477 | Boronkay et al. | Jun 2010 | B2 |
7744817 | Bui | Jun 2010 | B2 |
D621060 | Handique | Aug 2010 | S |
7785868 | Yuan et al. | Aug 2010 | B2 |
D628305 | Gorrec et al. | Nov 2010 | S |
7829025 | Ganesan et al. | Nov 2010 | B2 |
7858366 | Northrup et al. | Dec 2010 | B2 |
7867776 | Kennedy et al. | Jan 2011 | B2 |
D632799 | Canner et al. | Feb 2011 | S |
7892819 | Wilding et al. | Feb 2011 | B2 |
D637737 | Wilson et al. | May 2011 | S |
7955864 | Cox et al. | Jun 2011 | B2 |
7987022 | Handique et al. | Jul 2011 | B2 |
7998708 | Handique et al. | Aug 2011 | B2 |
8053214 | Northrup | Nov 2011 | B2 |
8071056 | Burns et al. | Dec 2011 | B2 |
8088616 | Handique | Jan 2012 | B2 |
8105783 | Handique | Jan 2012 | B2 |
8110158 | Handique | Feb 2012 | B2 |
8133671 | Williams et al. | Mar 2012 | B2 |
8182763 | Duffy et al. | May 2012 | B2 |
8246919 | Herchenbach et al. | Aug 2012 | B2 |
8273308 | Handique et al. | Sep 2012 | B2 |
D669597 | Cavada et al. | Oct 2012 | S |
8287820 | Williams et al. | Oct 2012 | B2 |
8323584 | Ganesan | Dec 2012 | B2 |
8323900 | Handique et al. | Dec 2012 | B2 |
8324372 | Brahmasandra et al. | Dec 2012 | B2 |
8415103 | Handique | Apr 2013 | B2 |
8420015 | Ganesan et al. | Apr 2013 | B2 |
8440149 | Handique | May 2013 | B2 |
8470586 | Wu et al. | Jun 2013 | B2 |
8473104 | Handique et al. | Jun 2013 | B2 |
D686749 | Trump | Jul 2013 | S |
D687567 | Jungheim et al. | Aug 2013 | S |
D692162 | Lentz et al. | Oct 2013 | S |
8592157 | Petersen et al. | Nov 2013 | B2 |
8679831 | Handique et al. | Mar 2014 | B2 |
D702854 | Nakahana et al. | Apr 2014 | S |
8685341 | Ganesan | Apr 2014 | B2 |
8703069 | Handique et al. | Apr 2014 | B2 |
8709787 | Handique | Apr 2014 | B2 |
8710211 | Brahmasandra et al. | Apr 2014 | B2 |
8734733 | Handique | May 2014 | B2 |
D710024 | Guo | Jul 2014 | S |
8765076 | Handique et al. | Jul 2014 | B2 |
8765454 | Zhou et al. | Jul 2014 | B2 |
8768517 | Handique et al. | Jul 2014 | B2 |
8852862 | Wu et al. | Oct 2014 | B2 |
8883490 | Handique et al. | Nov 2014 | B2 |
8894947 | Ganesan et al. | Nov 2014 | B2 |
8895311 | Handique et al. | Nov 2014 | B1 |
D729404 | Teich et al. | May 2015 | S |
9028773 | Ganesan | May 2015 | B2 |
9040288 | Handique et al. | May 2015 | B2 |
9051604 | Handique | Jun 2015 | B2 |
9080207 | Handique et al. | Jul 2015 | B2 |
D742027 | Lentz et al. | Oct 2015 | S |
9186677 | Williams et al. | Nov 2015 | B2 |
9217143 | Brahmasandra et al. | Dec 2015 | B2 |
9222954 | Lentz et al. | Dec 2015 | B2 |
9234236 | Thomas et al. | Jan 2016 | B2 |
9238223 | Handique | Jan 2016 | B2 |
9259734 | Williams et al. | Feb 2016 | B2 |
9259735 | Handique et al. | Feb 2016 | B2 |
9347586 | Williams et al. | May 2016 | B2 |
9480983 | Lentz et al. | Nov 2016 | B2 |
9528142 | Handique | Dec 2016 | B2 |
9618139 | Handique | Apr 2017 | B2 |
D787008 | Duffy et al. | Jun 2017 | S |
9670528 | Handique et al. | Jun 2017 | B2 |
9677121 | Ganesan et al. | Jun 2017 | B2 |
9701957 | Wilson et al. | Jul 2017 | B2 |
9745623 | Steel | Aug 2017 | B2 |
9765389 | Gubatayao et al. | Sep 2017 | B2 |
9789481 | Petersen et al. | Oct 2017 | B2 |
9802199 | Handique et al. | Oct 2017 | B2 |
9815057 | Handique | Nov 2017 | B2 |
9958466 | Dalbert et al. | May 2018 | B2 |
10065185 | Handique | Sep 2018 | B2 |
10071376 | Williams et al. | Sep 2018 | B2 |
10076754 | Lentz et al. | Sep 2018 | B2 |
10100302 | Brahmasandra et al. | Oct 2018 | B2 |
10139012 | Handique | Nov 2018 | B2 |
10179910 | Duffy et al. | Jan 2019 | B2 |
10234474 | Williams et al. | Mar 2019 | B2 |
10351901 | Ganesan et al. | Jul 2019 | B2 |
10364456 | Wu et al. | Jul 2019 | B2 |
10443088 | Wu et al. | Oct 2019 | B1 |
10494663 | Wu et al. | Dec 2019 | B1 |
10571935 | Handique et al. | Feb 2020 | B2 |
10590410 | Brahmasandra et al. | Mar 2020 | B2 |
10604788 | Wu et al. | Mar 2020 | B2 |
20010005489 | Roach et al. | Jun 2001 | A1 |
20010012492 | Acosta et al. | Aug 2001 | A1 |
20010016358 | Osawa et al. | Aug 2001 | A1 |
20010021355 | Baugh et al. | Sep 2001 | A1 |
20010023848 | Gjerde et al. | Sep 2001 | A1 |
20010038450 | McCaffrey et al. | Nov 2001 | A1 |
20010045358 | Kopf-Sill et al. | Nov 2001 | A1 |
20010046702 | Schmebri | Nov 2001 | A1 |
20010048899 | Marouiss et al. | Dec 2001 | A1 |
20010055765 | O'Keefe et al. | Dec 2001 | A1 |
20020001848 | Bedingham et al. | Jan 2002 | A1 |
20020008053 | Hansen et al. | Jan 2002 | A1 |
20020009015 | Laugharn, Jr. et al. | Jan 2002 | A1 |
20020014443 | Hansen et al. | Feb 2002 | A1 |
20020015667 | Chow | Feb 2002 | A1 |
20020021983 | Comte et al. | Feb 2002 | A1 |
20020022261 | Anderson et al. | Feb 2002 | A1 |
20020037499 | Quake et al. | Mar 2002 | A1 |
20020039783 | McMillan et al. | Apr 2002 | A1 |
20020047003 | Bedingham et al. | Apr 2002 | A1 |
20020053399 | Soane et al. | May 2002 | A1 |
20020054835 | Robotti et al. | May 2002 | A1 |
20020055167 | Pourahmadi et al. | May 2002 | A1 |
20020058332 | Quake et al. | May 2002 | A1 |
20020060156 | Mathies et al. | May 2002 | A1 |
20020068357 | Mathies et al. | Jun 2002 | A1 |
20020068821 | Gundling | Jun 2002 | A1 |
20020090320 | Burow et al. | Jul 2002 | A1 |
20020092767 | Bjornson et al. | Jul 2002 | A1 |
20020094303 | Yamamoto et al. | Jul 2002 | A1 |
20020131903 | Ingenhoven et al. | Sep 2002 | A1 |
20020141903 | Parunak et al. | Oct 2002 | A1 |
20020142471 | Handique et al. | Oct 2002 | A1 |
20020143297 | Francavilla et al. | Oct 2002 | A1 |
20020143437 | Handique et al. | Oct 2002 | A1 |
20020155010 | Karp et al. | Oct 2002 | A1 |
20020155477 | Ito | Oct 2002 | A1 |
20020169518 | Luoma et al. | Nov 2002 | A1 |
20020173032 | Zou et al. | Nov 2002 | A1 |
20020176804 | Strand et al. | Nov 2002 | A1 |
20020187557 | Hobbs et al. | Dec 2002 | A1 |
20020192808 | Gambini et al. | Dec 2002 | A1 |
20030008308 | Enzelberger et al. | Jan 2003 | A1 |
20030019522 | Parunak | Jan 2003 | A1 |
20030022392 | Hudak | Jan 2003 | A1 |
20030049174 | Ganesan | Mar 2003 | A1 |
20030049833 | Chen et al. | Mar 2003 | A1 |
20030059823 | Matsunaga et al. | Mar 2003 | A1 |
20030064507 | Gallagher et al. | Apr 2003 | A1 |
20030070677 | Handique et al. | Apr 2003 | A1 |
20030072683 | Stewart et al. | Apr 2003 | A1 |
20030073106 | Johansen et al. | Apr 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030087300 | Knapp et al. | May 2003 | A1 |
20030096310 | Hansen et al. | May 2003 | A1 |
20030099954 | Miltenyi et al. | May 2003 | A1 |
20030127327 | Kurnik | Jul 2003 | A1 |
20030136679 | Bohn et al. | Jul 2003 | A1 |
20030156991 | Halas et al. | Aug 2003 | A1 |
20030180192 | Seippel | Sep 2003 | A1 |
20030186295 | Colin et al. | Oct 2003 | A1 |
20030190608 | Blackburn et al. | Oct 2003 | A1 |
20030199081 | Wilding et al. | Oct 2003 | A1 |
20030211517 | Carulli et al. | Nov 2003 | A1 |
20040014202 | King et al. | Jan 2004 | A1 |
20040014238 | Krug et al. | Jan 2004 | A1 |
20040018116 | Desmond et al. | Jan 2004 | A1 |
20040018119 | Massaro | Jan 2004 | A1 |
20040022689 | Wulf et al. | Feb 2004 | A1 |
20040029258 | Heaney et al. | Feb 2004 | A1 |
20040029260 | Hansen et al. | Feb 2004 | A1 |
20040037739 | McNeely et al. | Feb 2004 | A1 |
20040043479 | Briscoe et al. | Mar 2004 | A1 |
20040053290 | Terbrueggen et al. | Mar 2004 | A1 |
20040063217 | Webster et al. | Apr 2004 | A1 |
20040065655 | Brown | Apr 2004 | A1 |
20040072278 | Chou et al. | Apr 2004 | A1 |
20040072375 | Gjerde et al. | Apr 2004 | A1 |
20040076996 | Kondo et al. | Apr 2004 | A1 |
20040086427 | Childers et al. | May 2004 | A1 |
20040086956 | Bachur | May 2004 | A1 |
20040132059 | Scurati et al. | Jul 2004 | A1 |
20040141887 | Mainquist et al. | Jul 2004 | A1 |
20040151629 | Pease et al. | Aug 2004 | A1 |
20040157220 | Kurnool et al. | Aug 2004 | A1 |
20040161788 | Chen et al. | Aug 2004 | A1 |
20040189311 | Glezer et al. | Sep 2004 | A1 |
20040197810 | Takenaka et al. | Oct 2004 | A1 |
20040200909 | McMillan et al. | Oct 2004 | A1 |
20040209331 | Ririe | Oct 2004 | A1 |
20040209354 | Mathies et al. | Oct 2004 | A1 |
20040219070 | Handique | Nov 2004 | A1 |
20040224317 | Kordunsky et al. | Nov 2004 | A1 |
20040235154 | Oh et al. | Nov 2004 | A1 |
20040240097 | Evans | Dec 2004 | A1 |
20050009174 | Nikiforov et al. | Jan 2005 | A1 |
20050013737 | Chow et al. | Jan 2005 | A1 |
20050019902 | Mathies et al. | Jan 2005 | A1 |
20050037471 | Liu et al. | Feb 2005 | A1 |
20050041525 | Pugia et al. | Feb 2005 | A1 |
20050042639 | Knapp et al. | Feb 2005 | A1 |
20050048540 | Inami et al. | Mar 2005 | A1 |
20050058574 | Bysouth et al. | Mar 2005 | A1 |
20050058577 | Micklash et al. | Mar 2005 | A1 |
20050064535 | Favuzzi et al. | Mar 2005 | A1 |
20050069898 | Moon et al. | Mar 2005 | A1 |
20050084424 | Ganesan et al. | Apr 2005 | A1 |
20050106066 | Saltsman et al. | May 2005 | A1 |
20050112754 | Yoon et al. | May 2005 | A1 |
20050121324 | Park et al. | Jun 2005 | A1 |
20050129580 | Swinehart et al. | Jun 2005 | A1 |
20050133370 | Park et al. | Jun 2005 | A1 |
20050135655 | Kopf-sill et al. | Jun 2005 | A1 |
20050142036 | Kim et al. | Jun 2005 | A1 |
20050152808 | Ganesan | Jul 2005 | A1 |
20050158781 | Woudenberg et al. | Jul 2005 | A1 |
20050170362 | Wada et al. | Aug 2005 | A1 |
20050186585 | Juncosa et al. | Aug 2005 | A1 |
20050196321 | Huang | Sep 2005 | A1 |
20050202470 | Sundberg et al. | Sep 2005 | A1 |
20050202489 | Cho et al. | Sep 2005 | A1 |
20050202504 | Anderson et al. | Sep 2005 | A1 |
20050208676 | Kahatt | Sep 2005 | A1 |
20050214172 | Burgisser | Sep 2005 | A1 |
20050220675 | Reed et al. | Oct 2005 | A1 |
20050227269 | Lloyd et al. | Oct 2005 | A1 |
20050233370 | Ammann et al. | Oct 2005 | A1 |
20050238545 | Parce et al. | Oct 2005 | A1 |
20050272079 | Burns et al. | Dec 2005 | A1 |
20050276728 | Muller-Cohn et al. | Dec 2005 | A1 |
20060002817 | Bohm et al. | Jan 2006 | A1 |
20060041058 | Yin et al. | Feb 2006 | A1 |
20060057039 | Morse et al. | Mar 2006 | A1 |
20060057629 | Kim | Mar 2006 | A1 |
20060062696 | Chow et al. | Mar 2006 | A1 |
20060094004 | Nakajima et al. | May 2006 | A1 |
20060094108 | Yoder et al. | May 2006 | A1 |
20060113190 | Kurnik | Jun 2006 | A1 |
20060133965 | Tajima et al. | Jun 2006 | A1 |
20060134790 | Tanaka et al. | Jun 2006 | A1 |
20060148063 | Fauzzi et al. | Jul 2006 | A1 |
20060165558 | Witty et al. | Jul 2006 | A1 |
20060165559 | Greenstein et al. | Jul 2006 | A1 |
20060166233 | Wu et al. | Jul 2006 | A1 |
20060177376 | Tomalia et al. | Aug 2006 | A1 |
20060177855 | Utermohlen et al. | Aug 2006 | A1 |
20060183216 | Handique | Aug 2006 | A1 |
20060201887 | Siddiqi | Sep 2006 | A1 |
20060205085 | Handique | Sep 2006 | A1 |
20060207944 | Siddiqi | Sep 2006 | A1 |
20060210435 | Alavie et al. | Sep 2006 | A1 |
20060223169 | Bedingham et al. | Oct 2006 | A1 |
20060228734 | Vann et al. | Oct 2006 | A1 |
20060246493 | Jensen et al. | Nov 2006 | A1 |
20060246533 | Fathollahi et al. | Nov 2006 | A1 |
20060269641 | Atwood et al. | Nov 2006 | A1 |
20060269961 | Fukushima et al. | Nov 2006 | A1 |
20070004028 | Lair et al. | Jan 2007 | A1 |
20070009386 | Padmanabhan et al. | Jan 2007 | A1 |
20070020699 | Carpenter et al. | Jan 2007 | A1 |
20070020764 | Miller | Jan 2007 | A1 |
20070026421 | Sundberg et al. | Feb 2007 | A1 |
20070042441 | Masters et al. | Feb 2007 | A1 |
20070048188 | Bigus | Mar 2007 | A1 |
20070054413 | Aviles et al. | Mar 2007 | A1 |
20070077648 | Okamoto et al. | Apr 2007 | A1 |
20070092901 | Ligler et al. | Apr 2007 | A1 |
20070098600 | Kayyem et al. | May 2007 | A1 |
20070099200 | Chow et al. | May 2007 | A1 |
20070104617 | Coulling et al. | May 2007 | A1 |
20070116613 | Elsener | May 2007 | A1 |
20070154895 | Spaid et al. | Jul 2007 | A1 |
20070177147 | Parce | Aug 2007 | A1 |
20070178607 | Prober et al. | Aug 2007 | A1 |
20070184463 | Molho et al. | Aug 2007 | A1 |
20070184547 | Handique et al. | Aug 2007 | A1 |
20070196237 | Neuzil et al. | Aug 2007 | A1 |
20070196238 | Kennedy et al. | Aug 2007 | A1 |
20070199821 | Chow | Aug 2007 | A1 |
20070215554 | Kreuwel et al. | Sep 2007 | A1 |
20070218459 | Miller et al. | Sep 2007 | A1 |
20070231213 | Prabhu et al. | Oct 2007 | A1 |
20070243626 | Windeyer et al. | Oct 2007 | A1 |
20070248958 | Jovanovich et al. | Oct 2007 | A1 |
20070261479 | Spaid et al. | Nov 2007 | A1 |
20070269861 | Williams et al. | Nov 2007 | A1 |
20070292941 | Handique et al. | Dec 2007 | A1 |
20080000774 | Park et al. | Jan 2008 | A1 |
20080003649 | Maltezos et al. | Jan 2008 | A1 |
20080017306 | Liu et al. | Jan 2008 | A1 |
20080050804 | Handique et al. | Feb 2008 | A1 |
20080056948 | Dale et al. | Mar 2008 | A1 |
20080069729 | McNeely | Mar 2008 | A1 |
20080075634 | Herchenbach et al. | Mar 2008 | A1 |
20080090244 | Knapp et al. | Apr 2008 | A1 |
20080095673 | Xu | Apr 2008 | A1 |
20080118987 | Eastwood et al. | May 2008 | A1 |
20080124723 | Dale et al. | May 2008 | A1 |
20080149840 | Handique et al. | Jun 2008 | A1 |
20080160601 | Handique | Jul 2008 | A1 |
20080176230 | Owen et al. | Jul 2008 | A1 |
20080182301 | Handique et al. | Jul 2008 | A1 |
20080192254 | Kim et al. | Aug 2008 | A1 |
20080226502 | Jonsmann et al. | Sep 2008 | A1 |
20080240898 | Manz et al. | Oct 2008 | A1 |
20080247914 | Edens et al. | Oct 2008 | A1 |
20080257882 | Turner | Oct 2008 | A1 |
20080262213 | Wu et al. | Oct 2008 | A1 |
20080280285 | Chen et al. | Nov 2008 | A1 |
20080308500 | Brassard | Dec 2008 | A1 |
20090047180 | Kawahara | Feb 2009 | A1 |
20090047713 | Handique | Feb 2009 | A1 |
20090066339 | Glezer et al. | Mar 2009 | A1 |
20090129978 | Wilson et al. | May 2009 | A1 |
20090130719 | Handique | May 2009 | A1 |
20090130745 | Williams et al. | May 2009 | A1 |
20090131650 | Brahmasandra et al. | May 2009 | A1 |
20090134069 | Handique | May 2009 | A1 |
20090136385 | Handique et al. | May 2009 | A1 |
20090136386 | Duffy et al. | May 2009 | A1 |
20090148933 | Battrell et al. | Jun 2009 | A1 |
20090155123 | Williams et al. | Jun 2009 | A1 |
20090189089 | Bedingham et al. | Jul 2009 | A1 |
20090221059 | Williams et al. | Sep 2009 | A1 |
20090223925 | Morse et al. | Sep 2009 | A1 |
20090325164 | Vossenaar et al. | Dec 2009 | A1 |
20090325276 | Battrell et al. | Dec 2009 | A1 |
20100009351 | Brahmasandra et al. | Jan 2010 | A1 |
20100120129 | Amshey et al. | May 2010 | A1 |
20100173393 | Handique et al. | Jul 2010 | A1 |
20100284864 | Holenstein et al. | Nov 2010 | A1 |
20110008825 | Ingber et al. | Jan 2011 | A1 |
20110027151 | Handique et al. | Feb 2011 | A1 |
20110097493 | Kerr et al. | Apr 2011 | A1 |
20110127292 | Sarofim et al. | Jun 2011 | A1 |
20110158865 | Miller et al. | Jun 2011 | A1 |
20110207140 | Handique et al. | Aug 2011 | A1 |
20110210257 | Handique et al. | Sep 2011 | A9 |
20110287447 | Norderhaug | Nov 2011 | A1 |
20110300033 | Battisti | Dec 2011 | A1 |
20120022695 | Handique et al. | Jan 2012 | A1 |
20120085416 | Ganesan | Apr 2012 | A1 |
20120122108 | Handique | May 2012 | A1 |
20120122231 | Tajima | May 2012 | A1 |
20120160826 | Handique | Jun 2012 | A1 |
20120171678 | Maltezos et al. | Jul 2012 | A1 |
20120171759 | Williams et al. | Jul 2012 | A1 |
20120183454 | Handique | Jul 2012 | A1 |
20120258463 | Duffy et al. | Oct 2012 | A1 |
20130037564 | Williams et al. | Feb 2013 | A1 |
20130071851 | Handique et al. | Mar 2013 | A1 |
20130096292 | Brahmasandra et al. | Apr 2013 | A1 |
20130101990 | Handique et al. | May 2013 | A1 |
20130164832 | Ganesan et al. | Jun 2013 | A1 |
20130183769 | Tajima | Jul 2013 | A1 |
20130217102 | Ganesan et al. | Aug 2013 | A1 |
20130280131 | Handique et al. | Oct 2013 | A1 |
20130288358 | Handique et al. | Oct 2013 | A1 |
20130315800 | Yin et al. | Nov 2013 | A1 |
20140030798 | Wu et al. | Jan 2014 | A1 |
20140045186 | Gubatayao et al. | Feb 2014 | A1 |
20140206088 | Lentz et al. | Jul 2014 | A1 |
20140212882 | Handique et al. | Jul 2014 | A1 |
20140227710 | Handique et al. | Aug 2014 | A1 |
20140297047 | Ganesan et al. | Oct 2014 | A1 |
20140323357 | Handique et al. | Oct 2014 | A1 |
20140323711 | Brahmasandra et al. | Oct 2014 | A1 |
20140329301 | Handique et al. | Nov 2014 | A1 |
20140342352 | Handique et al. | Nov 2014 | A1 |
20140377850 | Handique et al. | Dec 2014 | A1 |
20150045234 | Stone et al. | Feb 2015 | A1 |
20150064702 | Handique et al. | Mar 2015 | A1 |
20150118684 | Wu et al. | Apr 2015 | A1 |
20150133345 | Handique et al. | May 2015 | A1 |
20150142186 | Handique et al. | May 2015 | A1 |
20150152477 | Ganesan et al. | Jun 2015 | A1 |
20150174579 | Iten et al. | Jun 2015 | A1 |
20150315631 | Handique et al. | Nov 2015 | A1 |
20150328638 | Handique et al. | Nov 2015 | A1 |
20150376682 | Handique | Dec 2015 | A1 |
20160038942 | Roberts | Feb 2016 | A1 |
20160102305 | Brahmasandra et al. | Apr 2016 | A1 |
20160107161 | Lentz et al. | Apr 2016 | A1 |
20160250635 | Handique | Sep 2016 | A1 |
20160250640 | Williams et al. | Sep 2016 | A1 |
20160333337 | Duffy et al. | Nov 2016 | A1 |
20170097373 | Williams et al. | Apr 2017 | A1 |
20170275702 | Dahiya et al. | Sep 2017 | A1 |
20180112252 | Handique | Apr 2018 | A1 |
20180135102 | Gubatayao et al. | May 2018 | A1 |
20180154364 | Handique et al. | Jun 2018 | A1 |
20180333722 | Handique | Nov 2018 | A1 |
20190054467 | Handique | Feb 2019 | A1 |
20190054471 | Williams et al. | Feb 2019 | A1 |
20190106692 | Brahmasandra et al. | Apr 2019 | A1 |
20190144849 | Duffy et al. | May 2019 | A1 |
20190145546 | Handique | May 2019 | A1 |
20190151854 | Baum et al. | May 2019 | A1 |
20190154719 | LaChance et al. | May 2019 | A1 |
20190284606 | Wu et al. | Sep 2019 | A1 |
20190324050 | Williams et al. | Oct 2019 | A1 |
20190390255 | Wu et al. | Dec 2019 | A1 |
20200010872 | Ganesan et al. | Jan 2020 | A1 |
Number | Date | Country |
---|---|---|
1357102 | Mar 2002 | AU |
3557502 | Jul 2002 | AU |
4437602 | Jul 2002 | AU |
4437702 | Jul 2002 | AU |
764319 | Aug 2003 | AU |
2574107 | Sep 1998 | CA |
2294819 | Jan 1999 | CA |
1312287 | Apr 2007 | CN |
1942590 | Apr 2007 | CN |
1968754 | May 2007 | CN |
101466848 | Jun 2009 | CN |
101522909 | Sep 2009 | CN |
103540518 | Jan 2014 | CN |
19929734 | Dec 1999 | DE |
19833293 | Jan 2000 | DE |
0365828 | May 1990 | EP |
0483620 | May 1992 | EP |
0688602 | Dec 1995 | EP |
0766256 | Apr 1997 | EP |
0772494 | May 1997 | EP |
0810030 | Dec 1997 | EP |
1059458 | Dec 2000 | EP |
1064090 | Jan 2001 | EP |
1077086 | Feb 2001 | EP |
1346772 | Sep 2003 | EP |
1541237 | Jun 2005 | EP |
1574586 | Sep 2005 | EP |
1745153 | Jan 2007 | EP |
1780290 | May 2007 | EP |
1792656 | Jun 2007 | EP |
2372367 | Oct 2011 | EP |
2672301 | Aug 1992 | FR |
2795426 | Dec 2000 | FR |
2453432 | Apr 2009 | GB |
S50-100881 | Aug 1975 | JP |
58212921 | Dec 1983 | JP |
S62-119460 | May 1987 | JP |
H01-502319 | Aug 1989 | JP |
03-054470 | Mar 1991 | JP |
H 03181853 | Aug 1991 | JP |
04-053555 | May 1992 | JP |
06-064156 | Sep 1994 | JP |
07-020010 | Jan 1995 | JP |
H07-290706 | Nov 1995 | JP |
H08-122336 | May 1996 | JP |
H08-173194 | Jul 1996 | JP |
H08-211071 | Aug 1996 | JP |
H08-285859 | Nov 1996 | JP |
H08-337116 | Dec 1996 | JP |
H09-325151 | Dec 1997 | JP |
2001-502790 | Jan 1998 | JP |
H01-219669 | Sep 1998 | JP |
H10-327515 | Dec 1998 | JP |
H 11501504 | Feb 1999 | JP |
H 11503315 | Mar 1999 | JP |
2000-514928 | Apr 1999 | JP |
H 11316226 | Nov 1999 | JP |
H11-515106 | Dec 1999 | JP |
2000-180455 | Jun 2000 | JP |
2000-266760 | Sep 2000 | JP |
2000-275255 | Oct 2000 | JP |
2001-502319 | Feb 2001 | JP |
2001-204462 | Jul 2001 | JP |
2001-509437 | Jul 2001 | JP |
3191150 | Jul 2001 | JP |
2001-515216 | Sep 2001 | JP |
2001-523812 | Nov 2001 | JP |
2001-527220 | Dec 2001 | JP |
2002-503331 | Jan 2002 | JP |
2002-085961 | Mar 2002 | JP |
2002-517735 | Jun 2002 | JP |
2002-215241 | Jul 2002 | JP |
2002-540382 | Nov 2002 | JP |
2002-544476 | Dec 2002 | JP |
2003-500674 | Jan 2003 | JP |
2003-047839 | Feb 2003 | JP |
2003-047840 | Feb 2003 | JP |
2003-516125 | May 2003 | JP |
2003-164279 | Jun 2003 | JP |
2003-185584 | Jul 2003 | JP |
2003-299485 | Oct 2003 | JP |
2003-329693 | Nov 2003 | JP |
2003-329696 | Nov 2003 | JP |
2003-532382 | Nov 2003 | JP |
2004-003989 | Jan 2004 | JP |
2004-506179 | Feb 2004 | JP |
2004-150797 | May 2004 | JP |
2004-531360 | Oct 2004 | JP |
2004-533838 | Nov 2004 | JP |
2004-361421 | Dec 2004 | JP |
2004-536291 | Dec 2004 | JP |
2005-009870 | Jan 2005 | JP |
2005-010179 | Jan 2005 | JP |
2005-511264 | Apr 2005 | JP |
2005-514718 | May 2005 | JP |
2005-518825 | Jun 2005 | JP |
2005-176613 | Jul 2005 | JP |
2005-192439 | Jul 2005 | JP |
2005-192554 | Jul 2005 | JP |
2005-519751 | Jul 2005 | JP |
2005-204661 | Aug 2005 | JP |
2005-525816 | Sep 2005 | JP |
2005-291954 | Oct 2005 | JP |
2005-323519 | Nov 2005 | JP |
2005-533652 | Nov 2005 | JP |
2005-535904 | Nov 2005 | JP |
2006-021156 | Jan 2006 | JP |
2006-055837 | Mar 2006 | JP |
2006-094866 | Apr 2006 | JP |
2006-145458 | Jun 2006 | JP |
2006-167569 | Jun 2006 | JP |
2006-284409 | Oct 2006 | JP |
2007-024742 | Feb 2007 | JP |
2007-074960 | Mar 2007 | JP |
2007-097477 | Apr 2007 | JP |
2007-101364 | Apr 2007 | JP |
2007-510518 | Apr 2007 | JP |
2007-514405 | Jun 2007 | JP |
2007-178328 | Jul 2007 | JP |
2009-542207 | Dec 2009 | JP |
3193848 | Oct 2014 | JP |
2418633 | May 2011 | RU |
WO 8806633 | Sep 1988 | WO |
WO 9012350 | Oct 1990 | WO |
WO 9205443 | Apr 1992 | WO |
WO 9411103 | May 1994 | WO |
WO 9604547 | Feb 1996 | WO |
WO 1996018731 | Jun 1996 | WO |
WO 1996039547 | Dec 1996 | WO |
WO 9705492 | Feb 1997 | WO |
WO 9721090 | Jun 1997 | WO |
WO 9800231 | Jan 1998 | WO |
WO 9822625 | May 1998 | WO |
WO 199835013 | Aug 1998 | WO |
WO 9849548 | Nov 1998 | WO |
WO 9853311 | Nov 1998 | WO |
WO 1998050147 | Nov 1998 | WO |
WO 9901688 | Jan 1999 | WO |
WO 9909042 | Feb 1999 | WO |
WO 9912016 | Mar 1999 | WO |
WO 1999017093 | Apr 1999 | WO |
WO 1999029703 | Jun 1999 | WO |
WO 9933559 | Jul 1999 | WO |
WO 2000022436 | Apr 2000 | WO |
WO 01005510 | Jan 2001 | WO |
WO 01014931 | Mar 2001 | WO |
WO 01027614 | Apr 2001 | WO |
WO 01028684 | Apr 2001 | WO |
WO 2001030995 | May 2001 | WO |
WO 01041931 | Jun 2001 | WO |
WO 2001046474 | Jun 2001 | WO |
WO 01054813 | Aug 2001 | WO |
WO 01089681 | Nov 2001 | WO |
WO 2002048164 | Jun 2002 | WO |
WO 02072264 | Sep 2002 | WO |
WO 02078845 | Oct 2002 | WO |
WO 2002086454 | Oct 2002 | WO |
WO 2003007677 | Jan 2003 | WO |
WO 03012325 | Feb 2003 | WO |
WO 03012406 | Feb 2003 | WO |
WO 03048295 | Jun 2003 | WO |
WO 03055605 | Jul 2003 | WO |
WO 03076661 | Sep 2003 | WO |
WO 2003078065 | Sep 2003 | WO |
WO 03087410 | Oct 2003 | WO |
WO 04007081 | Jan 2004 | WO |
WO 2004010760 | Feb 2004 | WO |
WO 2004048545 | Jun 2004 | WO |
WO 04055522 | Jul 2004 | WO |
WO 2004056485 | Jul 2004 | WO |
WO 04074848 | Sep 2004 | WO |
WO 2004094986 | Nov 2004 | WO |
WO 2005008255 | Jan 2005 | WO |
WO 05011867 | Feb 2005 | WO |
WO 2005030984 | Apr 2005 | WO |
WO 2005072353 | Aug 2005 | WO |
WO 2005094981 | Oct 2005 | WO |
WO 05108620 | Nov 2005 | WO |
WO 2005107947 | Nov 2005 | WO |
WO 2005108571 | Nov 2005 | WO |
WO 2005116202 | Dec 2005 | WO |
WO 2005118867 | Dec 2005 | WO |
WO 2005120710 | Dec 2005 | WO |
WO 06010584 | Feb 2006 | WO |
WO 2006032044 | Mar 2006 | WO |
WO 2006035800 | Apr 2006 | WO |
WO 2006043642 | Apr 2006 | WO |
WO 06066001 | Jun 2006 | WO |
WO 06079082 | Jul 2006 | WO |
WO 2006081995 | Aug 2006 | WO |
WO 2006113198 | Oct 2006 | WO |
WO 06119280 | Nov 2006 | WO |
WO 07044917 | Apr 2007 | WO |
WO 07050327 | May 2007 | WO |
WO 07064117 | Jun 2007 | WO |
WO 2007075919 | Jul 2007 | WO |
WO 2007091530 | Aug 2007 | WO |
WO 2007112114 | Oct 2007 | WO |
WO 2008005321 | Jan 2008 | WO |
WO 08030914 | Mar 2008 | WO |
WO 08060604 | May 2008 | WO |
WO 2008149282 | Dec 2008 | WO |
WO 09012185 | Jan 2009 | WO |
WO 2009054870 | Apr 2009 | WO |
WO 10118541 | Oct 2010 | WO |
WO 2010130310 | Nov 2010 | WO |
WO 2010140680 | Dec 2010 | WO |
WO 2011009073 | Jan 2011 | WO |
WO 2011101467 | Aug 2011 | WO |
Entry |
---|
Bollet, C. et al., “A simple method for the isolation of chromosomal DNA from Gram positive or acid-fast bacteria”, Nucleic Acids Research, vol. 19, No. 8 (1991), p. 1955. |
Brahmasandra et al., On-chip DNA detection in microfabricated separation systems, SPIE Conference on Microfluidic Devices and Systems, 1998, vol. 3515, pp. 242-251, Santa Clara, CA. |
Breadmore, M.C. et al., “Microchip-Based Purification of DNA from Biological Samples”, Anal. Chem., vol. 75 (2003), pp. 1880-1886. |
Brody, et al., Diffusion-Based Extraction in a Microfabricated Device, Sensors and Actuators Elsevier, 1997, vol. A58, No. 1, pp. 13-18. |
Broyles et al., “Sample Filtration, Concentration, and Separation Integrated on Microfluidic Devices” Analytical Chemistry (American Chemical Society), (2003) 75(11): 2761-2767. |
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science 282:484-487 (1998). |
Chung, Y. et al., “Microfluidic chip for high efficiency DNA extraction”, Miniaturisation for Chemistry, Biology & Bioengineering, vol. 4, No. 2 (Apr. 2004), pp. 141-147. |
Handique et al, “Microfluidic flow control using selective hydrophobic patterning”, SPIE, (1997) 3224: 185-194. |
Handique et al., On-Chip Thermopneumatic Pressure for Discrete Drop Pumping, Analytical Chemistry, American Chemical Society, Apr. 15, 2001, vol. 73, No. 8, 1831-1838. |
Handique, K. et al., “Nanoliter-volume discrete drop injection and pumping in microfabricated chemical analysis systems”, Solid-State Sensor and Actuator Workshop (Hilton Head, South Carolina, Jun. 8-11, 1998) pp. 346-349. |
Handique, K. et al., “Mathematical Modeling of Drop Mixing in a Slit-Type Microchannel”, J. Micromech. Microeng., 11:548-554 (2001). |
Handique, K. et al., “Nanoliter Liquid Metering in Microchannels Using Hydrophobic Patterns”, Anal. Chem., 72:4100-4109 (2000). |
He, et al., Microfabricated Filters for Microfluidic Analytical Systems, Analytical Chemistry, American Chemical Society, 1999, vol. 71, No. 7, pp. 1464-1468. |
Ibrahim, et al., Real-Time Microchip PCR for Detecting Single-Base Differences in Viral and Human DNA, Analytical Chemistry, American Chemical Society, 1998, 70(9): 2013-2017. |
Khandurina et al., Microfabricated Porous Membrane Structure for Sample Concentration and Electrophoretic Analysis, Analytical Chemistry American Chemical Society, 1999, 71(9): 1815-1819. |
Kopp et al., Chemical Amplification: Continuous-Flow PCR on a Chip, www.sciencemag.org, 1998, vol. 280, pp. 1046-1048. |
Kutter et al., Solid Phase Extraction on Microfluidic Devices, J. Microcolumn Separations, John Wiley & Sons, Inc., 2000, 12(2): 93-97. |
Lagally et al., Single-Molecule DNA Amplification and Analysis in an Integrated Microfluidic Device, Analytical Chemistry, American Chemical Society, 2001, 73(3): 565-570. |
Livache et al., “Polypyrrole DNA chip on a Silicon Device: Example of Hepatitis C Virus Genotyping”, Analytical Biochemistry, (1998) 255: 188-194. |
Mascini et al., “DNA electrochemical biosensors”, Fresenius J. Anal. Chem., 369: 15-22, (2001). |
Nakagawa et al., Fabrication of amino silane-coated microchip for DNA extraction from whole blood, J of Biotechnology, Mar. 2, 2005, vol. 116, pp. 105-111. |
Northrup et al., A Miniature Analytical Instrument for Nucleic Acids Based on Micromachined Silicon Reaction Chambers, Analytical Chemistry, American Chemical Society, 1998, 70(5): 918-922. |
Oleschuk et al., Trapping of Bead-Based Reagents within Microfluidic Systems,: On-Chip Solid-Phase Extraction and Electrochromatography, Analytical Chemistry, American Chemical Society, 2000, 72(3): 585-590. |
Plambeck et al., “Electrochemical Studies of Antitumor Antibiotics”, J. Electrochem Soc.: Electrochemical Science and Technology (1984), 131(11): 2556-2563. |
Roche et al. “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells” Faseb J (2005) 19: 1341-1343. |
Ross et al., Analysis of DNA Fragments from Conventional and Microfabricated Pcr Devices Using Delayed Extraction MALDI-TOF Mass Spectrometry, Analytical Chemistry, American Chemical Society, 1998, 70(10): 2067-2073. |
Shoffner et al., Chip PCR.I. Surface Passivation of Microfabricated Silicon-Glass Chips for PCR, Nucleic Acids Research, Oxford University Press, (1996) 24(2): 375-379. |
Smith, K. et al., “Comparison of Commercial DNA Extraction Kits for Extraction of Bacterial Genomic DNA from Whole-Blood Samples”, Journal of Clinical Microbiology, vol. 41, No. 6 (Jun. 2003), pp. 2440-2443. |
Wang, “Survey and Summary, from DNA Biosensors to Gene Chips”, Nucleic Acids Research, 28(16):3011-3016, (2000). |
Waters et al., Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing, Analytical Chemistry, American Chemical Society, 1998, 70(1): 158-162. |
Weigl, et al., Microfluidic Diffusion-Based Separation and Detection, www.sciencemag.org, 1999, vol. 283, pp. 346-347. |
Yoza et al., “Fully Automated DNA Extraction from Blood Using Magnetic Particles Modified with a Hyperbranched Polyamidomine Dendrimer”, Journal of Bioscience and Bioengineering, 2003, 95(1): 21-26. |
Yoza et al., DNA extraction using bacterial magnetic particles modified with hyperbranched polyamidoamine dendrimer, Mar. 20, 2003, 101(3): 219-228. |
International Search Report and Written Opinion dated Jun. 13, 2013 in Application No. PCT/US2013/024494, filed Feb. 1, 2013. |
Kuo et al., “Remnant cationic dendrimers block RNA migration in electrophoresis after monophasic lysis”, J Biotech. (2007) 129: 383-390. |
Tanaka et al., “Modification of DNA extraction from maize using polyamidoamine-dendrimer modified magnetic particles”, Proceedings of the 74th Annual Meeting of the Electrochemical Society of Japan, Mar. 29, 2007; Faculty of Engineering, Science University of Tokyo; 2 pages. |
Wu et al., “Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes”, Chem Commun. (2005) 3: 313-315. |
Zhou et al., “Cooperative binding and self-assembling behavior of cationic low molecular-weight dendrons with RNA molecules”, Org Biomol Chem. (2006) 4(3): 581-585. |
Zhou et al., “PANAM dendrimers for efficient siRNA delivery and potent gene silencing”, Chem Comm.(Camb.) (2006) 22: 2362-2364. |
Goldmeyer et al., “Identification of Staphylococcus aureus and Determination of Methicillin Resistance Directly from Positive Blood Cultures by Isothermal Amplification and a Disposable Detection Device”, J Clin Microbiol. (Apr. 2008) 46(4): 1534-1536. |
Meyers, R.A., Molecular Biology and Biotechnology: A Comprehensive Desk Reference; VCH Publishers, Inc. New York, NY; (1995) pp. 418-419. |
Allemand et al., “pH-Dependent Specific Binding and Combing of DNA”, Biophys J. (Oct. 1997) 73(4): 2064-2070. |
Harding et al., “DNA isolation using Methidium-Spermine-Sepharose”, Meth Enzymol. (Feb. 1992) 216: 29-39. |
Harding et al., “Rapid isolation of DNA from complex biological samples using a novel capture reagent—methidium-spermine-sepharose”, Nucl Acids Res. (Sep. 1989) 17(17): 6947-6958. |
Labchem; “Sodium Hydroxide, 0.5N (0.5M)”; Safety Data Sheet, 2015; 8 pages. |
Oh K.W. et al., “A Review of Microvalves”, J Micromech Microeng. (2006) 16:R13-R39. |
Altet et al., [Eds.] “Thermal Transfer and Thermal Coupling in IC's”, Thermal Testing of Integrated Circuits; Chapter 2 (2002) Springer Science pp. 23-51. |
Ateya et al., “The good, the bad, and the tiny: a review of microflow cytometry”, Anal Bioanal Chem. (2008) 391(5):1485-1498. |
Auroux et al., “Miniaturised nucleic acid analysis”, Lab Chip. (2004) 4(6):534-546. |
Baechi et al., “High-density microvalve arrays for sample processing in PCR chips”, Biomed Microdevices. (2001) 3(3):183-190. |
Baker M., “Clever PCR: more genotyping, smaller volumes.” Nature Methods (May 2010) 70(5):351-356. |
Becker H. “Fabrication of Polymer Microfluidic Devices”, in Biochip Technology (2001), Chapter 4, pp. 63-96. |
Becker H., “Microfluidic Devices Fabricated by Polymer Hot Embossing,” in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002), Chapter 13, 32 pages. |
Becker H., “Microfluidics: A Technology Coming of Age”, Med Device Technol. (2008) 19(3):21-24. |
Becker et al., “Portable CE system with contactless conductivity detection in an injection molded polymer chip for on-site food analysis”, SPIE Proceedings MOEMS-MEMS 2008 Micro and Nanofabrication (2008) vol. 6886 in 8 pages. |
Becker H., “Hype, hope and hubris: the quest for the killer application in microfluidics”, Lab on a Chip, The Royal Society of Chemistry (2009) 9:2119-2122. |
Becker H., “Collective Wisdom”, Lab on a Chip, The Royal Society of Chemistry (2010) 10:1351-1354. |
Belgrader et al., “Rapid PCR for Identity Testing Using a Battery-Powered Miniature Thermal Cycler”, J Forensic Sci. (1998) 43(2):315-319. |
Belgrader et al., “A minisonicator to rapidly disrupt bacterial spores for DNA analysis.”, Anal Chem. (1999) 71(19):4232-4236. |
Belgrader et al., “Real-time PCR Analysis on Nucleic Acids Purified from Plasma Using a Silicon Chip”, Micro Total Analysis Systems 2000 (pp. 525-528). Springer, Dordrecht. |
Belgrader et al., “A microfluidic cartridge to prepare spores for PCR analysis”, Biosens Bioelectron. (2000) 14(10-11):849-852. |
Belgrader et al., “A Battery-Powered Notebook Thermal Cycler for Rapid Multiplex Real-Time PCR Analysis”, Anal Chem. (2001) 73(2):286-289. |
Belgrader et al., “Rapid and Automated Cartridge-based Extraction of Leukocytes from Whole Blood for Microsatellite DNA Analysis by Capillary Electrophoresis”, Clin Chem. (2001) 47(10):1917-1933. |
Belgrader et al., “A Rapid, Flow-through, DNA Extraction Module for Integration into Microfluidic Systems”, Micro Total Analysis Systems (2002) pp. 697-699). Springer, Dordrecht. |
Belgrader et al., “Development of a Battery-Powered Portable Instrumentation for Rapid PCR Analysis”, in Integrated Microfabicated Devices, (2002) Ch. 8, pp. 183-206, CRC Press. |
Bell M., “Integrated Microsystems in Clinical Chemistry”, in Integrated Microfabicated Devices, (2002) Ch. 16, pp. 415-435, CRC Press. |
Berthier et al., “Managing evaporation for more robust microscale assays Part 1. Volume loss in high throughput assays”, Lab Chip (2008) 8(6):852-859. |
Berthier et al., “Managing evaporation for more robust microscale assays Part 2. Characterization of convection and diffusion for cell biology”, Lab Chip (2008) 8(6):860-864. |
Berthier et al., “Microdrops,” in Microfluidics for Biotechnology (2006), Chapter 2, pp. 51-88. |
Biomerieux Press Release: “bioMérieux—2018 Financial Results,” dated Feb. 27, 2019, accessed at www.biomerieux.com, pp. 13. |
Blanchard et al., “Micro structure mechanical failure characterization using rotating Couette flow in a small gap”, J Micromech Microengin. (2005) 15(4):792-801. |
Blanchard et al., “Single-disk and double-disk viscous micropumps”, Sensors and Actuators A (2005) 122:149-158. |
Blanchard et al., “Performance and Development of a Miniature Rotary Shaft Pump”, J Fluids Eng. (2005) 127(4):752-760. |
Blanchard et al., “Single-disk and double-disk viscous micropump”, ASME 2004 Inter'l Mechanical Engineering Congress & Exposition, Nov. 13-20, 2004, Anaheim, CA, IMECE2004-61705:411-417. |
Blanchard et al., “Miniature Single-Disk Viscous Pump (Single-DVP), Performance Characterization”, J Fluids Eng. (2006) 128(3):602-610. |
Brahmasandra et al., “Microfabricated Devices for Integrated DNA Analysis”, in Biochip Technology by Cheng et al., [Eds.] (2001) pp. 229-250. |
Bu et al., “Design and theoretical evaluation of a novel microfluidic device to be used for PCR”, J Micromech Microengin. (2003) 13(4):S125-S130. |
Cady et al., “Real-time PCR detection of Listeria monocytogenes using an integrated microfluidics platform”, Sensors Actuat B. (2005) 107:332-341. |
Carlen et al., “Paraffin Actuated Surface Micromachined Valve,” in IEEE MEMS 2000 Conference, Miyazaki, Japan, (Jan. 2000) pp. 381-385. |
Carles et al., “Polymerase Chain Reaction on Microchips” in Methods in Molecular Biology—Microfluidic Techniques, Reviews & Protocols by Minteer S.D. [Ed.] Humana Press (2006), vol. 321; Chapter 11, pp. 131-140. |
Chang-Yen et al., “A novel integrated optical dissolved oxygen sensor for cell culture and micro total analysis systems”, IEEE Technical Digest MEMS International Conference Jan. 24, 2002, 4 pages. |
Chang-Yen et al., “A PDMS microfluidic spotter for fabrication of lipid microarrays”, IEEE 3rd EMBS Special Topic Conference May 12-15, 2005; 2 pages. |
Chang-Yen et al., “Design and fabrication of a multianalyte-capable optical biosensor using a multiphysics approach”, IEEE 3rd EMBS Special Topic Conference May 12-15, 2005; 2 pages. |
Chang-Yen et al., “A Novel PDMS Microfluidic Spotter for Fabrication of Protein Chips and Microarrays”, IEEE J of Microelectromech Sys. (2006) 15(5): 1145-1151. |
Chang-Yen et al., “Design, fabrication, and packaging of a practical multianalyte-capable optical biosensor,” J Microlith Microfab Microsyst. (2006) 5(2):021105 in 8 pages. |
Chang-Yen et al., “Spin-assembled nanofilms for gaseous oxygen sensing.” Sens Actuators B: Chemical (2007), 120(2):426-433. |
Chaudhari et al., “Transient Liquid Crystal Thermometry of Microfabricated PCR Vessel Arrays”, J Microelectro Sys., (1998) 7(4):345-355. |
Chen P-C., “Accelerating micro-scale PCR (polymerase chain reactor) for modular lab-on-a-chip system”, LSU Master's Theses—Digital Commons, (2006) 111 pages. |
Chen et al., “Total nucleic acid analysis integrated on microfluidic devices,” Lab on a Chip. (2007) 7:1413-1423. |
Cheng et al., “Biochip-Based Portable Laboratory”, Biochip Tech. (2001):296-289. |
Cho et al., “A facility for characterizing the steady-state and dynamic thermal performance of microelectromechanical system thermal switches”, Rev Sci Instrum. (2008) 79(3):034901-1 to -8. |
Chong et al., “Disposable Polydimethylsioxane Package for ‘Bio-Microfluidic System’”, IEEE Proceedings Electronic Components and Technology (2005); 5 pages. |
Chou et al., “A miniaturized cyclic PCR device—modeling and experiments”, Microelec Eng. (2002) 61-62:921-925. |
Christel et al., “Nucleic Acid Concentration and PCR for Diagnostic Applications”, in Micro Total Analysis Systems. (1998) D.J. Harrison et al. [Eds.] pp. 277-280. |
Christel et al., “Rapid, Automated Nucleic Acid Probe Assays Using Silicon Microstructures for Nucleic Acid Concentration”, J Biomech Eng. (1999) 121(1):22-27. |
Christensen et al., “Characterization of interconnects used in PDMS microfluidic systems”, J Micromech Microeng. (2005) 15:928 in 8 pages. |
Crews et al, “Rapid Prototyping of a Continuous-Flow PCR Microchip”, Proceedings of the AiChE Annual Meeting(Nov. 15, 2006) (335a) 3 pages. |
Crews et al., Thermal gradient PCR in a continuous-flow microchip. In Microfluidics, BioMEMS, and Medical Microsystems V; Jan. 2007; vol. 6465, p. 646504; 12 pages. |
Crews et al., “Continuous-flow thermal gradient PCR”, Biomed Microdevices. (2008) 10(2):187-195. |
Cui et al., “Electrothermal modeling of silicon PCR chips”, In MEMS Design, Fabrication, Characterization, and Packaging, (Apr. 2001) (vol. 4407, pp. 275-280. |
Cui et al., “Design and Experiment of Silicon PCR Chips,” Proc. SPIE 4755, Design, Test, Integration, and Packaging of MEMS/MOEMS 2002, (Apr. 19, 2002) pp. 71-76. |
Danaher Press Release: “Danaher to Acquire Cepheid for $53.00 per share, or approximately $4 Billion,” dated Sep. 6, 2016, accessed at www.danaher.com, pp. 3. |
Demchenko A.P., “The problem of self-calibration of fluorescence signal in microscale sensor systems”, Lab Chip. (2005) 5(11):1210-1223. |
Dineva et al., “Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings”, Analyst. (2007) 132(12):1193-1199. |
Dishinger et al., “Multiplexed Detection and Applications for Separations on Parallel Microchips”, Electophoresis. (2008) 29(16):3296-3305. |
Dittrich et al., “Single-molecule fluorescence detection in microfluidic channels—the Holy Grail in muTAS?”, Anal Bioanal Chem. (2005) 382(8):1771-1782. |
Dittrich et al., “Lab-on-a-chip: microfluidics in drug discovery”, Nat Rev Drug Discov. (2006) 5(3):210-208. |
Dunnington et al., “Approaches to Miniaturized High-Throughput Screening of Chemical Libraries”, in Integrated Microfabicated Devices, (2002) Ch. 15, pp. 371-414, CRC Press. |
Eddings et al., “A PDMS-based gas permeation pump for on-chip fluid handling in microfluidic devices”, J Micromech Microengin. (2006) 16(11):2396-2402. |
Edwards et al., “Micro Scale Purification Systems for Biological Sample Preparation”, Biomed Microdevices (2001) 3(3):211-218. |
Edwards et al., “A microfabricated thermal field-flow fractionation system”, Anal Chem. (2002) 74(6):1211-1216. |
Ehrlich et al., “Microfluidic devices for DNA analysis”, Trends Biotechnol. (1999) 17(8):315-319. |
El-Ali et al., “Simulation and experimental validation of a SU-8 based PCR thermocycler chip with integrated heaters and temperature sensor”, Sens Actuators A: Physical (2004) 110(1-3):3-10. |
Erickson et al., “Joule heating and heat transfer in poly(dimethylsiloxane) microfluidic systems”, Lab Chip (2003) 3(3):141-149. |
Erickson et al., “Integrated Microfluidic Devices”, Analytica Chim Acta. (2004) 507:11-26. |
Erill et al., “Development of a CMOS-compatible PCR chip: comparison of design and system strategies”, J Micromech Microengin. (2004) 14(11):1-11. |
Fair R.B., Digital microfluidics: is a true lab-on-a-chip possible? Microfluidics Nanofluid. (2007) 3:245-281. |
Fan et al., “Integrated Plastic Microfluidic Devices for Bacterial Detection”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds], (2007) Chapter 6, pp. 78-89. |
Fiorini et al., “Disposable microfluidic devices: fabrication, function, and application”, Biotechniques (2005) 38(3):429-446. |
Frazier et al., “Integrated micromachined components for biological analysis systems”, J Micromech. (2000) 1(1):67-83. |
Gale et al., “Micromachined electrical field-flow fractionation (mu-EFFF) system”, IEEE Trans Biomed Eng. (1998) 45(12):1459-1469. |
Gale et al., “Geometric scaling effects in electrical field flow fractionation. 1. Theoretical analysis”, Anal Chem. (2001) 73(10):2345-2352. |
Gale et al., “BioMEMS Education at Louisiana Tech University”, Biomed Microdevices, (2002) 4:223-230. |
Gale et al., “Geometric scaling effects in electrical field flow fractionation. 2. Experimental results”, Anal Chem. (2002) 74(5):1024-1030. |
Gale et al., “Cyclical electrical field flow fractionation”, Electrophoresis. (2005) 26(9):1623-1632. |
Gale et al., “Low-Cost MEMS Technologies”, Elsevier B.V. (2008), Chapter 1.12; pp. 342-372. |
Garst et al., “Fabrication of Multilayered Microfluidic 3D Polymer Packages”, IEEE Proceedings Electronic Components & Tech, Conference May/Jun. 2005, pp. 603-610. |
Gärtner et al., “Methods and instruments for continuous-flow PCR on a chip”, Proc. SPIE 6465, Microfluidics, BioMEMS, and Medical Microsystems V, (2007) 646502; 8 pages. |
Giordano et al., “Toward an Integrated Electrophoretic Microdevice for Clinical Diagnostics”, in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002) Chapter 1; pp. 1-34. |
Graff et al., “Nanoparticle Separations Using Miniaturized Field-flow Fractionation Systems”, Proc. Nanotechnology Conference and Trade Show (NSTI) (2005); pp. 8-12. |
Greer et al., “Comparison of glass etching to xurography prototyping of microfluidic channels for DNA melting analysis”, J Micromech Microengin. (2007) 17(12):2407-2413. |
Grunenwald H., “Optimization of Polymerase Chain Reactions,” in Methods in Molecular Biology, PCR Protocols., Second Edition by Bartlett et al. [Eds.] Humana Press (2003) vol. 226, pp. 89-99. |
Guijt et al., “Chemical and physical processes for integrated temperature control in microfluidic devices”, Lab Chip. (2003) 3(1):1-4. |
Gulliksen A., “Microchips for Isothermal Amplification of RNA”, Doctoral Thesis (2007); Department of Mol. Biosciences—University of Oslo; 94 pages. |
Guttenberg et al., “Planar chip device for PCR and hybridization with surface acoustic wave pump”, Lab Chip. (2005) 5(3):308-317. |
Haeberle et al., “Microfluidic platforms for lab-on-a-chip applications”, Lab Chip. (2007) 7(9):1094-1110. |
Handal et al., “DNA mutation detection and analysis using miniaturized microfluidic systems”, Expert Rev Mol Diagn. (2006) 6(1):29-38. |
Hansen et al., “Microfluidics in structural biology: smaller, faster . . . better”, Curr Opin Struct Biol. (2003) 13(5):538-544. |
Heid et al., “Genome Methods—Real Time Quantitative PCR”, Genome Res. (1996) 6(10):986-994. |
Henry C.S. [Ed], “Microchip Capillary electrophoresis”, Methods in Molecular Biology, Humana Press 339 (2006) Parts I-IV in 250 pages. |
Herr et al., “Investigation of a miniaturized capillary isoelectric focusing (cIEF) system using a full-field detection approach”, Solid State Sensor and Actuator Workshop, Hilton Head Island (2000), pp. 4-8. |
Herr et al., “Miniaturized Isoelectric Focusing (μIEF) As a Component of a Multi-Dimensional Microfluidic System”, Micro Total Analysis Systems (2001) pp. 51-53. |
Herr et al., Miniaturized Capillary Isoelectric Focusing (cIEF): Towards a Portable High-Speed Separation Method. In Micro Total Analysis Systems (2000) Springer, Dordrecht; pp. 367-370. |
Holland et al., “Point-of-care molecular diagnostic systems—past, present and future”, Curr Opin Microbiol. (2005) 8(5):504-509. |
Hong et al., “Integrated nanoliter systems”, Nat Biotechnol. (2003) 21(10):1179-1183. |
Hong et al., “Molecular biology on a microfluidic chip”, J Phys.: Condens Matter (2006) 18(18):S691-S701. |
Hong et al., “Integrated Nucleic Acid Analysis in Parallel Matrix Architecture”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds], (2007) Chapter 8, pp. 107-116. |
Horsman et al., “Forensic DNA Analysis on Microfluidic Devices: A Review”, J Forensic Sci. (2007) 52(4):784-799. |
Hsieh et al., “Enhancement of thermal uniformity for a microthermal cycler and its application for polymerase chain reaction”, Sens Actuators B: Chemical. (2008) 130(2):848-856. |
Huang et al., “Temperature Uniformity and DNA Amplification Efficiency in Micromachined Glass PCR Chip”, TechConnect Briefs; Tech Proc. of the 2005 NSTI Nanotechnology Conference and Trade Show. (2005) vol. 1:452-455. |
Huebner et al., “Microdroplets: A sea of applications?”, Lab Chip. (2008) 8(8):1244-1254. |
Iordanov et al., “PCT Array on Chip—Thermal Characterization”, IEEE Sensors (2003) Conference Oct. 22-24, 2003; pp. 1045-1048. |
Irawan et al., “Cross-Talk Problem on a Fluorescence Multi-Channel Microfluidic Chip System,” Biomed Micro. (2005) 7(3):205-211. |
Ji et al., “DNA Purification Silicon Chip”, Sensors and Actuators A: Physical (2007) 139(1-2):139-144. |
Jia et al., “A low-cost, disposable card for rapid polymerase chain reaction”, Colloids Surfaces B: Biointerfaces (2007) 58:52-60. |
Kaigala et al., “An inexpensive and portable microchip-based platform for integrated RT-PCR and capillary electophoresis”, The Analyst (2008) 133(3):331-338. |
Kajiyama et al., “Genotyping on a Thermal Gradient DNA Chip”, Genome Res. (2003) 13(3):467-475. |
Kang et al., “Simulation and Optimization of a Flow-Through Micro PCR Chip”, NSTI-Nanotech (2006) vol. 2, pp. 585-588. |
Kantak et al.,“Microfluidic platelet function analyzer for shear-induced platelet activation studies”, 2nd Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Med and Biol. (May 2002) 5 pages. |
Kantak et al., “Microfabricated cyclical electrical field flow fractionation”, 7th International Conference on Miniaturized Chomical and Biochem Analysis Sys. (2003) pp. 1199-1202. |
Kantak et al., “Platelet function analyzer: Shear activation of platelets in microchannels”, Biomedical Microdevices (2003) 5(3):207-215. |
Kantak et al., “Characterization of a microscale cyclical electrical field flow fractionation system”, Lab Chip. (2006) 6(5):645-654. |
Kantak et al., “Effect of carrier ionic strength in microscale cyclical electrical field-flow fractionation”, Anal Chem. (2006) 78(8):2557-2564. |
Kantak et al., “Improved theory of cyclical electrical field flow fractions”, Electrophoresis (2006) 27(14):2833-2843. |
Karunasiri et al.,“Extraction of thermal parameters of microbolometer infrared detectors using electrical measurement”, SPIE's Inter'l Symposium on Optical Science, Engineering, and Instrumentation; Proceedings (1998) vol. 3436, Infrared Technology and Applications XXIV; (1998) 8 pages. |
Kelly et al., “Microfluidic Systems for Integrated, High-Throughput DNA Analysis,” Analytical Chemistry, (2005), 97A-102A, Mar. 1, 2005, in 7 pages. |
Khandurina et al., “Bioanalysis in microfluidic devices,” J Chromatography A, (2002) 943:159-183. |
Kim et al., “Reduction of Microfluidic End Effects in Micro-Field Flow Fractionation Channels”, Proc. MicroTAS 2003, pp. 5-9. |
Kim et al., “Multi-DNA extraction chip based on an aluminum oxide membrane integrated into a PDMS microfluidic structure”, 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Med and Biol. (May 2005). |
Kim et al., “Geometric optimization of a thin film ITO heater to generate a uniform temperature distribution”, (2006), Tokyo, Japan; pp. 293-295; Abstract. |
Kim et al., “Micro-Raman thermometry for measuring the temperature distribution inside the microchannel of a polymerase chain reaction chip”, J Micromech Microeng. (2006) 16(3):526-530. |
Kim et al., “Patterning of a Nanoporous Membrane for Multi-sample DNA Extraction”, J Micromech Microeng. (2006) 16:33-39. |
Kim et al., “Performance evaluation of thermal cyclers for PCR in a rapid cycling condition”, Biotechniques. (2008) 44(4):495-505. |
Kim et al., “Quantitative and qualitative analysis of a microfluidic DNA extraction system using a nanoporous AIO(x) membrane”, Lab Chip. (2008) 8(9):1516-1523. |
Kogi et al., “Microinjection-microspectroscopy of single oil droplets in water: an application to liquid/liquid extraction under solution-flow conditions”, Anal Chim Acta. (2000) 418(2):129-135. |
Kopf-Sill et al., “Creating a Lab-on-a-Chip with Microfluidic Technologies”, in Integrated Microfabricated Biodevices: Advanced Technologies for Genomics, Drug Discovery, Bioanalysis, and Clinical Diagnostics (2002) Chapter 2; pp. 35-54. |
Kricka L.J., “Microchips, Bioelectronic Chips, and Gene Chips—Microanalyzers for the Next Century”, in Biochip Technology by Cheng et al. [Eds]; (2006) Chapter 1, pp. 1-16. |
Krishnan et al., “Polymerase chain reaction in high surface-to-volume ratio SiO2 microstructures”, Anal Chem. (2004) 76(22):6588-6593. |
Kuswandi et al., “Optical sensing systems for microfluidic devices: a review”, Anal Chim Acta. (2007) 601(2):141-155. |
Lagally et al., “Genetic Analysis Using Portable PCR-CE Microsystem”, Proceedings 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems (2003) pp. 1283-1286. |
Lagally et al., “Integrated portable genetic analysis microsystem for pathogen/infectious disease detection”, Anal Chem. (2004) 76(11):3152-3170. |
Lauerman L.H., “Advances in PCR technology”, Anim Health Res Rev. (2004) 5(2):247-248. |
Lawyer et al., “High-level Expression, Purification, and Enzymatic Characterization of Full-length Thermus aquaticus DNA Polymerase and a Truncated Form Deficient in 5′to 3′Exonuclease Activity.” Genome research (1993) 2(4):275-287. |
Lee et al., “Submicroliter-volume PCR chip with fast thermal response and very power consumption”, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, (2003) pp. 187-190. |
Lee et al., “Bulk-micromachined submicroliter-volume PCR chip with very rapid thermal response and low power consumption”, Lab Chip. (2004) 4(4):401-407. |
Lewin et al., “Use of Real-Time PCR and Molecular Beacons to Detect Virus Replication in Human Immunodeficiency Virus Type 1-infected Individuals on Prolonged Effective Antiretroviral Therapy”. J Virol. (1999) 73(7), 6099-6103. |
Li et al., “Effect of high-aspect-ratio microstructures on cell growth and attachment”, 1st Annual Inter'l IEEE-EMBS Special Topic Conference on Microtechnologies in Med and Biol. Proceedings Cat. No. 00EX451; (Oct. 2000) Poster 66, pp. 531-536. |
Li PCH., “Micromachining Methods et al.” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 2-3 to 2-5; pp. 10-49. |
Li PCH., “Microfluidic Flow” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 3, pp. 55-99. |
Li PCH., “Detection Methods” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 7, pp. 187-249. |
Li PCH., “Applications to Nucleic Acids Analysis” in Microfluidic Lab-on-a-Chip for Chemical and Biological Analysis and Discovery, CRC Press (2005), Chapter 9; pp. 293-325. |
Li et al., “A Continuous-Flow Polymerase Chain Reaction Microchip With Regional Velocity Control”, J Microelectromech Syst. (2006) 15(1):223-236. |
Liao et al., “Miniature RT-PCR system for diagnosis of RNA-based viruses,” Nucl Acids Res. (2005) 33(18):e156 in 7 pages. |
Lien et al., “Integrated reverse transcription polymerase chain reaction systems for virus detection”, Biosens Bioelectron. (2007) 22(8):1739-1748. |
Lien et al., “Microfluidic Systems Integrated with a Sample Pretreatment Device for Fast Nucleic-Acid Amplification”, J Microelectro Sys. (2008) 17(2):288-301. |
Lifesciences et al., “Microfluidics in commercial applications; an industry perspective.” Lab Chip (2006) 6:1118-1121. |
Lin et al., “Thermal Uniformity of 12-in Silicon Wafer During Rapid Thermal Processing by Inverse Heat Transfer Method,” IEEE Transactions on Semiconductor Manufacturing, (2000) 13(4):448-456. |
Lin et al., “Simulation and experimental validation of micro polymerase chain reaction chips”, Sens Actuators B: Chemical. (2000) 71(1-2):127-133. |
Linder et al., “Microfluidics at the Crossroad with Point-of-care Diagnostics”, Analyst (2007) 132:1186-1192. |
Liu et al., “Integrated portable polymerase chain reaction-capillary electrophoresis microsystem for rapid forensic short tandem repeat typing”, Anal Chem. (2007) 79(5):1881-1889. |
Liu et al. [Eds], Integrated Biochips for DNA Analysis—Biotechnology Intelligence Unit; Springer/Landes Bioscience (2007) ISBN:978-0-387-76758-1; 216 pages. |
Locascio et al., “ANYL 67 Award Address—Microfluidics as a tool to enable research and discovery in the life sciences”, Abstract; The 236th ACS National Meeting (Aug. 2008); 2 pages. |
Mahjoob et al., “Rapid microfluidic thermal cycler for polymerase chain reaction nucleic acid amplification”, Inter'l J Heat Mass Transfer. (2008) 51(9-10):2109-2122. |
Manz et al., “Miniaturized Total Chemical Analysis Systems: a Novel Concept for Chemical Sensing,” Sensors and Actuators B1, (1990) 244-248. |
Marcus et al., “Parallel picoliter rt-PCR assays using microfluidics”, Anal Chem. (2006) 78(3):956-958. |
Mariella R.P. Jr., “Microtechnology”, Thrust Area Report FY 96 UCRL-ID-125472; Lawrence Livermore National Lab., CA (Feb. 1997) Chapter 3 in 44 pages. |
Mariella R., “Sample preparation: the weak link in microfluidics-based biodetection”, Biomed Microdevices. (2008) 10(6):777-784. |
McMillan et al., “Application of advanced microfluidics and rapid PCR to analysis of microbial targets”, In Proceedings of the 8th international symposium on microbial ecology (1999), in 13 pages. |
Melin et al., “Microfluidic large-scale integration: the evolution of design rules for biological automation”, Annu Rev Biophys Biomol Struct. (2007) 36:213-231. |
Merugu et al., “High Throughput Separations Using a Microfabricated Serial Electric Split Ssystem” (2003), Proceedings of μTAS 2003, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, Oct. 5-9, 2003, Squaw Valley, California; 1191-1194, in 3 pages. |
Miao et al., “Low cost micro-PCR array and micro-fluidic integration on single silicon chip”, Int'l J Comput Eng Science (2003) 4(2):231-234. |
Miao et al., “Flip-Chip packaged micro-plate for low cost thermal multiplexing”, Int'l J Comput Eng Science. (2003) 4(2):235-238. |
Micheletti et al., “Microscale Bioprocess Optimisation”, Curr Opin Biotech. (2006) 17:611-618. |
MicroTAS 2005., “Micro Total Analysis Systems”, Proceedings 9th Int. Conference on Miniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Boston, MA in Oct. 10-12, 2005 in 1667 pages. |
MicroTAS 2007., “Micro Total Analysis Systems”, Proceedings 11th Int. Conference on Miniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Paris, France in Oct. 7-11, 2007 in 1948 pages. |
MicroTAS 2007., “Micro Total Analysis Systems”, Advance Program for the Proceedings 11th Int. Conference on Miniaturized Systems for Chemistry and Life Sciences; Presentations/Posters/Articles for Conference; Paris, France in Oct. 7-11, 2007 in 42 pages. |
Minco, “Conductive Heating Technologies for Medical Diagnostic Equipment,” (2006) in 13 pages. |
Mitchell et al., “Modeling and validation of a molded polycarbonate continuous-flow polymerase chain reaction device,” Microfluidics, BioMEMS, and Medical Microsystems, Proc. SPIE (2003) 4982:83-98. |
Myers et al., “Innovations in optical microfluidic technologies for point-of-care diagnostics”, Lab Chip (2008) 8:2015-2031. |
Namasivayam et al., “Advances in on-chip photodetection for applications in miniaturized genetic analysis systems”, J Micromech Microeng. (2004) 14:81-90. |
Narayanan et al., “A microfabricated electrical SPLITT system,” Lab Chip, (2006) 6:105-114. |
Neuzil et al., “Disposable real-time microPCR device: lab-on-a-chip at a low cost, ” Mol. Biosyst., (2006) 2:292-298. |
Neuzil et al., “Ultra fast miniaturized real-time PCR: 40 cycles in less than six minutes,” Nucleic Acids Research, (2006) 34(11)e77, in 9 pages. |
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Microfluidics” in Fundamentals and Applications of Microfluidics; 2nd Edition (2006) Introduction Chapter 1, pp. 1-9. |
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Microvalves” in Fundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 6, pp. 211-254. |
Nguyen et al. [Eds], “Microfluidics for Internal Flow Control: Micropumps” in Fundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 7, pp. 255-309. |
Nguyen et al. [Eds], “Microfluidics for Life Sciences and Chemistry: Microdispensers” in Fundamentals and Applications of Microfluidics; (2006) , Chapter 11, pp. 395-418. |
Nguyen et al. [Eds], “Microfluidics for Life Sciences and Chemistry: Microreactors” in Fundamentals and Applications of Microfluidics; (2006) 2nd Edition, Chapter 13, pp. 443-477. |
Ning et al., “Microfabrication Processes for Silicon and Glass Chips”, in Biochip Technology, CRC-Press (2006) Chapter 2, pp. 17-38. |
Northrup et al., “A MEMs-based Miniature DNA Analysis System,” Lawrence Livermore National Laboratory, (1995), submitted to Transducers '95, Stockholm, Sweden, Jun. 25-29, 1995, in 7 pages. |
Northrup et al., “Advantages Afforded by Miniaturization and Integration of DNA Analysis Instrumentation,” Microreaction Technology, (1998) 278-288. |
Northrup et al., “A New Generation of PCR Instruments and Nucleic Acid Concentration Systems,” in PCR Applications: Protocols for Functional Genomics, (1999), Chapter 8, pp. 105-125. |
Northrup, “Microfluidics, A few good tricks,” Nature materials (2004), 3:282-283. |
Northrup et al.,“Microfluidics-based integrated airborne pathogen detection systems,” Abstract, Proceedings of the SPIE, (2006), vol. 6398, Abstract in 2 pages. |
Oh et al., “World-to-chip microfluidic interface with built-in valves for multichamber chip-based PCR assays,” Lab Chip, (2005), 5:845-850. |
Ohno et al., “Microfluidics: Applications for analytical purposes in chemistry and biochemistry,” Electrophoresis (2008), 29:4443-4453. |
Pal et al., “Phase Change Microvalve for Integrated Devices,” Anal. Chem. (2004), 76(13):3740-3748, Jul. 1, 2004, in 9 pages. |
Pal et al., “An integrated microfluidic for influenza and other genetic analyses,” Lab Chip, (2005), 5:1024-1032, in 9 pages. |
Pamme, “Continuous flow separations in microfluidic devices,” Lab Chip, (2007), 7:1644-1659. |
Pang et al., “A novel single-chip fabrication technique for three-dimensional MEMS structures,” Institute of Microelectronics, Tsinghua University, Beijing, P.R. China, (1998), IEEE, 936-938. |
Pang et al., “The Study of Single-Chip Integrated Microfluidic System,” Tsinghua University, Beijing, P.R. China, (1998), IEEE, 895-898. |
Papautsky et al., “Effects of rectangular microchannel aspect ratio on laminar friction constant”, in Microfluidic Devices and Systems II (1999) 3877:147-158. |
Petersen, Kurt E., “Silicon as a Mechanical Material.” Proceedings of the IEEE, (May 1982) 70(5):420-457. |
Petersen et al., “Toward Next Generation Clinical Diagnostic Instruments: Scaling and New Processing Paradigms,” Biomedical Microdevices (1998) 1(1):71-79. |
Picard et al., Laboratory Detection of Group B Streptococcus for Prevention of Perinatal Disease, Eur. J. Clin. Microbiol. Infect. Dis., Jul. 16, 2004, 23: 665-671. |
Poser et al., “Chip elements for fast thermocycling,” Sensors and Actuators A, (1997), 62:672-675. |
Pourahmadi et al., “Toward a Rapid, Integrated, and Fully Automated DNA Diagnostic Assay for Chlamydia trachomatis and Neisseria gonorrhea,” Clinical Chemistry, (2000), 46(9):1511-1513. |
Pourahmadi et al., “Versatile, Adaptable and Programmable Microfluidic Platforms for DNA Diagnostics and Drug Discovery Assays,” Micro Total Analysis Systems, (2000), 243-248. |
Raisi et al., “Microchip isoelectric focusing using a miniature scanning detection system,” Electrophoresis, (2001), 22:2291-2295. |
Raja et al., “Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcriptin—PCR Clinical Testing,” Clinical Chemistry, (2005), 51(5):882-890. |
Reyes et al., “Micro Total Analysis Systems. 1. Introduction, Theory, and Technology”, Anal Chem (2002) 74:2623-2636. |
Rodriguez et al., “Practical integration of polymerase chain reaction amplification and electrophoretic analysis in microfluidic devices for genetic analysis,” Electrophoresis, (2003), 24:172-178. |
Rohsenow et al. [Eds.], Handbook of Heat Transfer, 3rd Edition McGraw-Hill Publishers (1998) Chapters 1 & 3; pp. 108. |
Roper et al., “Advances in Polymer Chain Reaction on Microfluidic Chips,” Anal. Chem., (2005), 77:3887-3894. |
Ross et al., “Scanning Temperature Gradient Focusing for Simultaneous Concentration and Separation of Complex Samples,” Micro Total Analysis Systems 2005, vol. 2, (2005), Proceedings of μTAS 2005, Ninth International Conference on Miniaturized Systems for Chemistry and Life Sciences, Oct. 9-13, 2005, Boston, Massachusetts; 1022-1024. |
Ross et al., “Simple Device for Multiplexed Electrophoretic Separations Using Gradient Elution Moving Boundary Electrophoresis with Channel Current Detection,” Anal. Chem., (2008), 80(24):9467-9474. |
Sadler et al., “Thermal Management of BioMEMS: Temperature Control for Ceramic-Based PCR and DNA Detection Devices,” IEEE Transactions on Components and Packaging Technologies, (2003) 26(2):309-316. |
Sant et al., “An Integrated Optical Detector for Microfabricated Electrical Field Flow Fractionation System,” Proceedings of μTAS 2003, 7th International Conference on Miniaturized Chemical and Biochemical Analysis Systems, Oct. 5-9, 2003, Squaw Valley, California; pp. 1259-1262. |
Sant et al., “Geometric scaling effects on instrumental plate height in field flow fractionation”, J Chromatography A (2006) 1104:282-290. |
Sant H.J., “Reduction of End Effect-Induced Zone Broadening in Field-Flow Fractionation Channels”, Anl Chem. (2006) 78:7978-7985. |
Sant et al., “Microscale Field-Flow Fractionation: Theory and Practice”, in Microfluidic Technologies for Miniaturized Analysis Systems. (2007) Chapter 12, pp. 4710521,. |
Schäferling et al., “Optical technologies for the read out and quality control of DNA and protein microarrays,” Anal Bioanal Chem, (2006), 385: 500-517. |
Serpengüzel et al., “Microdroplet identification and size measurement in sprays with lasing images”, Optics express (2002) 10(20):1118-1132. |
Shackman et al., “Gradient Elution Moving Boundary Electrophoresis for High-Throughput Multiplexed Microfluidic Devices,” Anal. Chem. (2007), 79(2), 565-571. |
Shackman et al., “Temperature gradient focusing for microchannel separations,” Anal Bioanal Chem, (2007), 387:155-158. |
Shadpour et al., “Multichannel Microchip Electrophoresis Device Fabricated in Polycarbonate with an Integrated Contact Conductivity Sensor Array,” Anal Chem., (2007), 79(3), 870-878. |
Shen et al., “A microchip-based PCR device using flexible printed circuit technology,” Sensors and Actuators B (2005), 105:251-258. |
Sia et al., “Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies,” Electrophoresis, (2003), 24:3563-3576. |
Sigurdson M., “AC Electrokinetic Enhancement for Assay Enhancement”, ProQuest LLC (2008) Doctoral Thesis UMI Microform 3319791 in 24 pages. |
Singh et al., “PCR thermal management in an integrated Lab on Chip,” Journal of Physics: Conference Series, (2006), 34:222-227. |
Situma et al., “Merging microfluidics with microarray-based bioassays”, Biomol Engin. (2006) 23:213-231. |
Smith et al., “(576d) Micropatterned fluid lipid bilayers created using a continuous flow microspotter for multi-analyte assays,” (2007), Biosensors II, 2007 AlChE Annual Meeting, Nov. 8, 2007, Abstract in 2 pages. |
Sommer et al., “Introduction to Microfluidics”, in Microfluidics for Biological Applications by Tian et al. [Eds] (2008) Chapter 1, pp. 1-34. |
Spitzack et al., “Polymerase Chain Reaction in Miniaturized Systems: Big Progress in Little Devices”, in Methods in Molecular Biology—Microfluidic Techniques, Minteer S.D. [Ed.] Humana Press (2006), Chapter 10, pp. 97-129. |
Squires et al., “Microfluidics: Fluid physics at the nanoliter scale”, Rev Modern Phys. (2005) 77(3):977-1026. |
Sundberg et al., “Solution-phase DNA mutation scanning and SNP genotyping by nanoliter melting analysis,” Biomed Microdevices, (2007), 9:159-166, in 8 pages. |
Tabeling, P. [Ed.], “Physics at the micrometric scale,” in Introduction to Microfluidics (2005) Chapter 1, pp. 24-69. |
Tabeling, P. [Ed.], “Hydrodynamics of Microfluidic Systems”, in Introduction to Microfluidics; (2005) Chapter 2, pp. 70-129. |
Tabeling, P. [Ed.], Introduction to Microfluidics; (2005) Chapters 5-7, pp. 216-297. |
Taylor et al., Fully Automated Sample Preparation for Pathogen Detection Performed in a Microfluidic Cassette, in Micro Total Analysis Systems, Springer (2001), pp. 670-672. |
Taylor et al., “Lysing Bacterial Spores by Sonication through a Flexible Interface in a Microfluidic System,” Anal. Chem., (2001), 73(3):492-496. |
Taylor et al., “Microfluidic Bioanalysis Cartridge with Interchangeable Microchannel Separation Components,” (2001), The 11th International Conference on Solid-State Sensors and Actuators, Jun. 10-14, 2001, Munich, Germany; 1214-1247. |
Taylor et al., “Disrupting Bacterial Spores and Cells using Ultrasound Applied through a Solid Interface,” (2002), 2nd Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine & Biology, May 2-4, 2002, Madison, Wisconsin; 551-555. |
Thorsen et al., “Microfluidic Large-scale integration,” Science, (2002), 298:580-584. |
Toriello et al., “Multichannel Reverse Transcription-Polymerase Chain Reaction Microdevice for Rapid Gene Expression and Biomarker Analysis,” Anal. Chem., (2006) 78(23):7997-8003. |
Ugaz et al., “Microfabricated electrophoresis systems for DNA sequencing and genotyping applications,” Phil. Trans. R. Soc. Lond. A, (2004), 362:1105-1129. |
Ugaz et al., “PCR in Integrated Microfluidic Systems”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds]; (2007) Chapter 7, pp. 90-106. |
Ullman et al., “Luminescent oxygen channeling assay (LOCI™): sensitive, broadly applicable homogeneous immunoassay method”. Clin Chem. (1996) 42(9), 1518-1526. |
Velten et al., “Packaging of Bio-MEMS: Strategies, Technologies, and Applications,” IEEE Transactions on Advanced Packaging, (2005) 28(4):533-546. |
Vinet et al., “Microarrays and microfluidic devices: miniaturized systems for biological analysis,” Microelectronic Engineering, (2002), 61-62:41-47. |
Wang et al., “From biochips to laboratory-on-a-chip system”, in Genomic Signal Processing and Statistics by Dougherty et al. [Eds]; (2005) Chapter 5, pp. 163-200. |
Wang et al., “A disposable microfluidic cassette for DNA amplification and detection”, Lab on a Chip (2006) 6(1):46-53. |
Wang et al., “Micromachined Flow-through Polimerase Chain Reaction Chip Utilizing Multiple Membrane-activated Micropumps,” (2006), MEMS 2006, Jan. 22-26, 2006, Istanbul, Turkey; 374-377. |
Woolley A.T., “Integrating Sample Processing and Detection with Microchip Capillary Electrophoresis of DNA”, in Integrated Biochips for DNA Analysis by Liu et al. [Eds]; (2007) Chapter 5, pp. 68-77. |
Xiang et al., “Real Time PCR on Disposable PDMS Chip with a Miniaturized Thermal Cycler,” Biomedical Microdevices, (2005), 7(4):273-279. |
Xuan, “Joule heating in electrokinetic flow,” Electrophoresis, (2008), 298:33-43. |
Yang et al., “High sensitivity PCR assay in plastic micro reactors,” Lab Chip, (2002), 2:179-187. |
Yang et al., “An independent, temperature controllable-microelectrode array,” Anal. Chem., (2004), 76(5):1537-1543. |
Yang et al., “Cost-effective thermal isolation techniques for use on microfabricated DNA amplification and analysis devices,” J Micromech Microeng, (2005), 15:221-230. |
Yobas et al., Microfluidic Chips for Viral RNA Extraction & Detection, (2005), 2005 IEEE, 49-52. |
Yobas et al., “Nucleic Acid Extraction, Amplification, and Detection on Si-Based Microfluidic Platforms,” IEEE Journal of Solid-State Circuits, (2007), 42(8):1803-1813. |
Yoon et al., “Precise temperature control and rapid thermal cycling in a micromachined DNA polymer chain reaction chip,” J. Micromech. Microeng., (2002), 12:813-823. |
Zhang et al, “Temperature analysis of continuous-flow micro-PCR based on FEA,” Sensors and Actuators B, (2002), 82:75-81. |
Zhang et al, “Continuous-Flow PCR Microfluidics for Rapid DNA Amplification Using Thin Film Heater with Low Thermal Mass,” Analytical Letters, (2007), 40:1672-1685, in 15 pages. |
Zhang et al, “Direct Adsorption and Detection of Proteins, Including Ferritin, onto Microlens Array Patterned Bioarrays,” J Am Chem Soc., (2007), 129:9252-9253. |
Zhang et al, “Micropumps, microvalves, and micromixers within PCR microfluidic chips: Advances and trens,” Biotechnology Advances, (2007), 25:483-514. |
Zhang et al., “Miniaturized PCR chips for nucleic acid amplification and analysis: latest advances and future trends,” Nucl Acids Res., (2007) 35(13):4223-4237. |
Zhao et al, “Heat properties of an integrated micro PCR vessel,” Proceedings of SPIE, (2001), International Conference on Sensor Technology, 4414:31-34. |
Zou et al., “Micro-assembled multi-chamber thermal cycler for low-cost reaction chip thermal multiplexing,” Sensors and Actuators A, (2002), 102:114-121. |
Zou et al., “Miniaturized Independently Controllable Multichamber Thermal Cycler,” IEEE Sensors Journal, (2003), 3(6):774-780. |
Patent Owner's Response in Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Paper 25 in IPR2019-00490) dated Oct. 16, 2019 (80 pages). |
Patent Owner's Response in Inter Partes Review of U.S. Pat. No. 7,998,708 and Exhibit List (Paper 25 in IPR 2019-00488) dated Oct. 16, 2019 (93 pages). |
Transcript of Deposition of Bruce K. Gale, Ph.D., in Support of Patent Owner's Responses (Exhibit 2012 in IPR2019-00488 and IPR2019-00490), taken Sep. 24, 2019 (124 pages). |
Declaration of M. Allen Northrup, Ph.D. in Support of Patent Owner's Responses (Exhibit 2036 in IPR2019-00488 and IPR2019-00490) dated Oct. 16, 2019 (365 pages). |
Petitioner's Reply to Patent Owner's Response to Petition in Inter Partes Review of U.S. Pat. No. 7,998,708 and Exhibit List (Paper 32 in IPR 2019-00488) dated Jan. 31, 2020 (34 pages). |
Petitioner's Reply to Patent Owner's Response to Petition in Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Paper 32 in IPR 2019-00490) dated Jan. 31, 2020 (35 pages). |
Second Declaration of Bruce K. Gale, Ph.D. (Exhibit 1026 in IPR2019-00488 and IPR2019-00490) dated Jan. 31, 2020 (91 pages). |
Transcript of Deposition of M. Allen Northrup, Ph.D., (Exhibit 1027 in IPR2019-00488 and IPR2019-00490), taken Dec. 19, 2019 (109 pages). |
Patent Owner's Sur-Reply in Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 42 in IPR2019-00490) dated Mar. 12, 2020 (39 pages). |
Patent Owner's Sur-Reply in Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 43 in IPR 2019-00488) dated Mar. 12, 2020 (41 pages). |
Transcript of Second Deposition of Bruce K. Gale, Ph.D., (Exhibit 2068 in IPR2019-00488 and IPR2019-00490), taken Feb. 19, 2020 (352 pages). |
Complaint filed by Becton, Dickinson et al., v. NeuModx Molecular, Inc. on Jun. 18, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS, Infringement Action involving U.S. Pat. Nos. 7,998,708; 8,273,308; 8,323,900; 8,415,103; 8,703,069; and 8,709,787 (29 pages). |
Answer to Complaint filed by NeuModx Molecular, Inc. on Aug. 9, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (24 pages). |
Amended Answer to Complaint filed by NeuModx Molecular, Inc. on Oct. 4, 2019 in U.S. District Court, Delaware, Case #1:19-cv-01126-LPS (31 pages). |
Cooley et al., “Applications of Ink-Jet Printing Technology to BioMEMS and Microfluidic Systems”, Proceedings, SPIE Conference on Microfluids and BioMEMS, (Oct. 2001), 12 pages. |
Edwards, “Silicon (Si),” in “Handbook of Optical Constants of Solids” (Ghosh & Palik eds., 1997) in 24 pages. |
Hale et al., “Optical constants of Water in the 200-nm to 200-μm Wavelength Region”, Applied Optics, 12(3): 555-563 (1973). |
Kim et al., “Electrohydrodynamic Generation and Delivery of Monodisperse Picoliter Droplets Using a Poly(dimethylsiloxane) Microchip”, Anal Chem. (2006) 78: 8011-8019. |
Malitson, “Interspecimen Comparison of the Refractive Index of Fused Silica,” J Optical Society of America, 55:1205-1209 (1965). |
Mastrangelo et al., Microfabricated Devices for Genetic Diagnostics. Proceedings of the IEEE (1998) 86(8):1769-1787. |
Pal et al., “Phase Change Microvalve for Integrated Devices”, Anal Chem. (2004) 76: 3740-3748. |
Palina et al., “Laser Assisted Boron Doping of Silicon Wafer Solar Cells Using Nanosecond and Picosecond Laser Pulses,” 2011 37th IEEE Photovoltaic Specialists Conference, pp. 002193-002197, IEEE (2011). |
Paulson et al., “Optical dispersion control in surfactant-free DNA thin films by vitamin B2 doping,” Nature, Scientific Reports 8:9358 (2018) published at www.nature.com/scientificreports, Jun. 19, 2018. |
Sanchez et al., “Linear-After-The-Exponential (LATE)-PCR: An advanced method of asymmetric PCR and its uses in quantitative real-time analysis”, PNAS (2004) 101(7): 1933-1938. |
Zhang et al., “PCR Microfluidic Devices for DNA Amplification,” Biotechnology Advances, 24:243-284 (2006). |
Zou et al., “A Micromachined Integratable Thermal Reactor,” technical digest from International Electron Devices Meeting, IEEE, Washington, D.C., Dec. 2-5, 2001 (6 pages). |
Petition for Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 1 in IPR2019-00488) dated Dec. 20, 2018 (94 pages). |
Declaration of Bruce K. Gale, Ph.D. (Exhibit 1001 in IPR2019-00488 and IPR2019-00490) dated Dec. 20, 2018 (235 pages). |
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 7,998,708 and Exhibit List (Papers 5 and 6 in IPR2019-00488) dated Apr. 18, 2019 (79 pages). |
Decision instituting Inter Partes Review of U.S. Pat. No. 7,998,708 (Paper 8 in IPR2019-00488) dated Jul. 16, 2019 (20 pages). |
Petition for Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 1 in IPR2019□00490) dated Dec. 20, 2018 (85 pages). |
Declaration of Michael G. Mauk, Ph.D. in Support of Patent Owner Preliminary Responses in IPR2019-00488 and IPR2019-00490 dated Apr. 18, 2019 (43 pages). |
Patent Owner Preliminary Response to Petition for Inter Partes Review of U.S. Pat. No. 8,323,900 and Exhibit List (Papers 5 and 6 in IPR2019-00490) dated Apr. 18, 2019 (73 pages). |
Decision instituting Inter Partes Review of U.S. Pat. No. 8,323,900 (Paper 8 in IPR2019-00490) dated Jul. 16, 2019 (23 pages). |
Number | Date | Country | |
---|---|---|---|
20130217013 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
61594867 | Feb 2012 | US |